Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	methyl-CpG binding	MBD3L5 MBD3L2 MBD3L3 MBD3L4 MBD3L2B	6.90e-06	31	175	5	GO:0008327
GeneOntologyMolecularFunction	aminoacyltransferase activity	UBR2 RNF166 MKRN2 COP1 G2E3 ATE1 TRIM3 RNF157 FBXL5 MALT1 MARCHF5 TRIM8 BTRC MGRN1	2.58e-04	532	175	14	GO:0016755
GeneOntologyMolecularFunction	ubiquitin-protein transferase activity	UBR2 RNF166 MKRN2 COP1 G2E3 TRIM3 RNF157 FBXL5 MALT1 MARCHF5 TRIM8 BTRC MGRN1	2.84e-04	473	175	13	GO:0004842
GeneOntologyMolecularFunction	vitamin E binding	AFM NPC1L1	4.53e-04	4	175	2	GO:0008431
GeneOntologyMolecularFunction	ubiquitin protein ligase activity	UBR2 RNF166 MKRN2 COP1 G2E3 TRIM3 RNF157 MARCHF5 TRIM8 BTRC MGRN1	4.56e-04	372	175	11	GO:0061630
GeneOntologyBiologicalProcess	protein polyubiquitination	UBR2 RNF166 KBTBD6 MKRN2 TTC36 G2E3 KBTBD7 TRIM3 MARCHF5 TRIM8 TNKS2 BTRC MGRN1	1.12e-06	289	174	13	GO:0000209
GeneOntologyBiologicalProcess	negative regulation of Ras protein signal transduction	EPHB2 TGFB2 RASA4 MFN2 RASA4B	3.39e-06	28	174	5	GO:0046580
GeneOntologyBiologicalProcess	regulation of small GTPase mediated signal transduction	EPHB2 GPR4 CDC42BPA KBTBD6 ARHGEF5 IQSEC2 KBTBD7 TGFB2 RASA4 IQSEC1 MFN2 RASA4B NOTCH2	5.30e-06	333	174	13	GO:0051056
GeneOntologyBiologicalProcess	regulation of Ras protein signal transduction	EPHB2 TGFB2 RASA4 MFN2 RASA4B NOTCH2	1.25e-05	61	174	6	GO:0046578
GeneOntologyBiologicalProcess	DNA methylation-dependent constitutive heterochromatin formation	MBD3L5 MBD3L2 MBD3L3 MBD3L4 MBD3L2B	3.36e-05	44	174	5	GO:0006346
GeneOntologyBiologicalProcess	small GTPase-mediated signal transduction	EPHB2 GPR4 RALGDS CDC42BPA KBTBD6 ARHGEF5 IQSEC2 KBTBD7 TGFB2 RASA4 AGTR1 IQSEC1 MFN2 RASA4B NOTCH2	5.38e-05	538	174	15	GO:0007264
GeneOntologyBiologicalProcess	heterochromatin formation	UBR2 MBD3L5 MBD3L2 MBD3L3 MBD3L4 MBD3L2B MOV10L1 UTY	7.47e-05	163	174	8	GO:0031507
GeneOntologyBiologicalProcess	receptor-mediated endocytosis involved in cholesterol transport	ABCA2 LDLR PCSK9	9.26e-05	11	174	3	GO:0090118
GeneOntologyBiologicalProcess	facultative heterochromatin formation	MBD3L5 MBD3L2 MBD3L3 MBD3L4 MBD3L2B	9.97e-05	55	174	5	GO:0140718
GeneOntologyBiologicalProcess	Ras protein signal transduction	EPHB2 RALGDS TGFB2 RASA4 MFN2 RASA4B NOTCH2	1.08e-04	128	174	7	GO:0007265
GeneOntologyCellularComponent	PCSK9-LDLR complex	LDLR PCSK9	6.97e-05	2	175	2	GO:1990666
GeneOntologyCellularComponent	COPII vesicle coat	SEC24C SEC23B SEC23A	2.98e-04	16	175	3	GO:0030127
GeneOntologyCellularComponent	extracellular matrix	VWF ZAN LAMB1 MUC5B TECTA SVEP1 TGFB2 FBN1 EFEMP1 HMCN2 OTOGL ADAMTS18 LOXL4 ALB FBN3	4.27e-04	656	175	15	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	VWF ZAN LAMB1 MUC5B TECTA SVEP1 TGFB2 FBN1 EFEMP1 HMCN2 OTOGL ADAMTS18 LOXL4 ALB FBN3	4.41e-04	658	175	15	GO:0030312
GeneOntologyCellularComponent	basement membrane	LAMB1 TGFB2 FBN1 EFEMP1 HMCN2 ALB	5.73e-04	122	175	6	GO:0005604
GeneOntologyCellularComponent	endolysosome membrane	TLR7 LDLR PCSK9	5.92e-04	20	175	3	GO:0036020
GeneOntologyCellularComponent	connexin complex	GJD2 GJA9 GJA10	7.90e-04	22	175	3	GO:0005922
HumanPheno	Perifollicular hyperkeratosis	KRT81 KRT83 KRT86	9.43e-06	4	69	3	HP:0007468
HumanPheno	Abnormal mitral valve physiology	ERAP1 SPEG TLR7 AIP ADNP LDLR FBN1 MTX2 ALDH18A1 NOTCH2 PCSK9	2.41e-05	180	69	11	HP:0031481
HumanPheno	Abnormal mitral valve morphology	VWF ERAP1 SPEG TLR7 AIP ADNP LDLR TGFB2 FBN1 MTX2 ALDH18A1 NOTCH2 PCSK9	3.09e-05	257	69	13	HP:0001633
HumanPheno	Abnormal perifollicular morphology	KRT81 KRT83 KRT86	4.62e-05	6	69	3	HP:0031285
HumanPheno	Abnormal atrioventricular valve morphology	VWF ERAP1 SPEG TLR7 AIP ADNP LDLR NR2F2 TGFB2 FBN1 MTX2 SEC24C ALDH18A1 NOTCH2 PCSK9	4.93e-05	350	69	15	HP:0006705
HumanPheno	Mitral regurgitation	ERAP1 SPEG TLR7 AIP ADNP LDLR FBN1 MTX2 ALDH18A1 PCSK9	5.69e-05	163	69	10	HP:0001653
HumanPheno	Abnormal atrioventricular valve physiology	ERAP1 SPEG TLR7 AIP ADNP LDLR FBN1 MTX2 ALDH18A1 NOTCH2 PCSK9	1.23e-04	215	69	11	HP:0031650
HumanPheno	Deformed sella turcica	SLC17A5 MTX2 ALDH18A1 NOTCH2	1.27e-04	20	69	4	HP:0002681
Domain	Growth_fac_rcpt_	EPHB2 TMEM67 KRT83 LAMB1 LDLR SVEP1 THBD FBN1 EFEMP1 HMCN2 SLIT3 LRP2 ADGRE5 FBN3 NOTCH2	1.41e-11	156	171	15	IPR009030
Domain	EGF_Ca-bd_CS	TPO LDLR SVEP1 THBD FBN1 EFEMP1 HMCN2 SLIT3 LRP2 ADGRE5 FBN3 NOTCH2	8.55e-11	97	171	12	IPR018097
Domain	EGF_CA	TPO LDLR SVEP1 THBD FBN1 EFEMP1 HMCN2 SLIT3 LRP2 ADGRE5 FBN3 NOTCH2	1.09e-10	99	171	12	PS01187
Domain	EGF-type_Asp/Asn_hydroxyl_site	TPO LDLR SVEP1 THBD FBN1 EFEMP1 HMCN2 SLIT3 LRP2 ADGRE5 FBN3 NOTCH2	2.46e-10	106	171	12	IPR000152
Domain	EGF_CA	TPO LDLR SVEP1 THBD FBN1 EFEMP1 HMCN2 LRP2 ADGRE5 FBN3 NOTCH2	3.71e-10	86	171	11	PF07645
Domain	EGF-like_dom	TPO ZAN ADAM15 LAMB1 TECTA LDLR SVEP1 THBD FBN1 EFEMP1 HMCN2 SLIT3 LRP2 ADGRE5 FBN3 NOTCH2	1.21e-09	249	171	16	IPR000742
Domain	EGF_CA	TPO LDLR SVEP1 THBD FBN1 EFEMP1 HMCN2 SLIT3 LRP2 ADGRE5 FBN3 NOTCH2	1.28e-09	122	171	12	SM00179
Domain	EGF-like_Ca-bd_dom	TPO LDLR SVEP1 THBD FBN1 EFEMP1 HMCN2 SLIT3 LRP2 ADGRE5 FBN3 NOTCH2	1.54e-09	124	171	12	IPR001881
Domain	ASX_HYDROXYL	TPO LDLR SVEP1 THBD FBN1 EFEMP1 HMCN2 LRP2 ADGRE5 FBN3 NOTCH2	1.92e-09	100	171	11	PS00010
Domain	EGF	TPO ZAN ADAM15 LAMB1 TECTA LDLR SVEP1 THBD FBN1 EFEMP1 SLIT3 LRP2 ADGRE5 FBN3 NOTCH2	4.48e-09	235	171	15	SM00181
Domain	EGF_2	EPHB2 TPO ZAN ADAM15 LAMB1 LDLR SVEP1 THBD FBN1 EFEMP1 HMCN2 SLIT3 LRP2 FBN3 NOTCH2	2.26e-08	265	171	15	PS01186
Domain	EGF_3	TPO ZAN ADAM15 LDLR SVEP1 THBD FBN1 EFEMP1 HMCN2 SLIT3 LRP2 ADGRE5 FBN3 NOTCH2	3.58e-08	235	171	14	PS50026
Domain	EGF_1	TPO ZAN ADAM15 LAMB1 LDLR SVEP1 THBD FBN1 EFEMP1 HMCN2 SLIT3 LRP2 FBN3 NOTCH2	9.90e-08	255	171	14	PS00022
Domain	TIL_dom	VWF ZAN MUC5B TECTA LRP2	1.14e-07	14	171	5	IPR002919
Domain	EGF-like_CS	TPO ZAN ADAM15 LAMB1 LDLR SVEP1 THBD FBN1 EFEMP1 HMCN2 SLIT3 LRP2 FBN3 NOTCH2	1.32e-07	261	171	14	IPR013032
Domain	MeCpG-bd_2/3_C_dom	MBD3L5 MBD3L2 MBD3L3 MBD3L4	2.32e-07	7	171	4	IPR025884
Domain	MBD2/MBD3_p55-bd	MBD3L5 MBD3L2 MBD3L3 MBD3L4	2.32e-07	7	171	4	IPR032343
Domain	MBDa	MBD3L5 MBD3L2 MBD3L3 MBD3L4	2.32e-07	7	171	4	PF16564
Domain	MBD_C	MBD3L5 MBD3L2 MBD3L3 MBD3L4	2.32e-07	7	171	4	PF14048
Domain	C8	VWF ZAN MUC5B TECTA	3.17e-06	12	171	4	PF08742
Domain	TIL	VWF ZAN MUC5B TECTA	3.17e-06	12	171	4	PF01826
Domain	cEGF	THBD FBN1 EFEMP1 LRP2 FBN3	3.42e-06	26	171	5	PF12662
Domain	cEGF	THBD FBN1 EFEMP1 LRP2 FBN3	3.42e-06	26	171	5	IPR026823
Domain	VWF_A	ITGA11 VWF SVEP1 ANTXRL HMCN2 SEC24C SEC23B SEC23A	3.53e-06	99	171	8	IPR002035
Domain	Unchr_dom_Cys-rich	VWF ZAN MUC5B TECTA	4.55e-06	13	171	4	IPR014853
Domain	C8	VWF ZAN MUC5B TECTA	4.55e-06	13	171	4	SM00832
Domain	VWF_type-D	VWF ZAN MUC5B TECTA	1.13e-05	16	171	4	IPR001846
Domain	VWFD	VWF ZAN MUC5B TECTA	1.13e-05	16	171	4	PS51233
Domain	VWD	VWF ZAN MUC5B TECTA	1.13e-05	16	171	4	SM00216
Domain	VWD	VWF ZAN MUC5B TECTA	1.13e-05	16	171	4	PF00094
Domain	Sec23/24_helical_dom	SEC24C SEC23B SEC23A	1.48e-05	6	171	3	IPR006900
Domain	Sec23_24_beta_S	SEC24C SEC23B SEC23A	1.48e-05	6	171	3	IPR012990
Domain	zf-Sec23_Sec24	SEC24C SEC23B SEC23A	1.48e-05	6	171	3	PF04810
Domain	Sec23_trunk	SEC24C SEC23B SEC23A	1.48e-05	6	171	3	PF04811
Domain	Sec23_helical	SEC24C SEC23B SEC23A	1.48e-05	6	171	3	PF04815
Domain	Sec23_BS	SEC24C SEC23B SEC23A	1.48e-05	6	171	3	PF08033
Domain	Sec23/24_trunk_dom	SEC24C SEC23B SEC23A	1.48e-05	6	171	3	IPR006896
Domain	Znf_Sec23_Sec24	SEC24C SEC23B SEC23A	1.48e-05	6	171	3	IPR006895
Domain	-	UBR2 ZMYND11 RNF166 MKRN2 ZNF521 COP1 DIDO1 G2E3 TRIM3 RNF157 ZFPL1 MARCHF5 TRIM8 ZFYVE26 MGRN1	1.70e-05	449	171	15	3.30.40.10
Domain	EGF	ZAN TECTA SVEP1 THBD SLIT3 LRP2 FBN3 NOTCH2	2.10e-05	126	171	8	PF00008
Domain	Znf_RING/FYVE/PHD	UBR2 ZMYND11 RNF166 MKRN2 ZNF521 COP1 DIDO1 G2E3 TRIM3 RNF157 ZFPL1 MARCHF5 TRIM8 ZFYVE26 MGRN1	2.20e-05	459	171	15	IPR013083
Domain	VWC_out	VWF ZAN MUC5B TECTA	2.36e-05	19	171	4	SM00215
Domain	VWFC_2	VWF ZAN MUC5B TECTA CHRD	2.38e-05	38	171	5	PS50184
Domain	VWC	VWF ZAN MUC5B TECTA CHRD	2.38e-05	38	171	5	SM00214
Domain	VWF_dom	VWF ZAN MUC5B TECTA CHRD	3.92e-05	42	171	5	IPR001007
Domain	Znf_RING	UBR2 ZMYND11 RNF166 MKRN2 COP1 G2E3 TRIM3 RNF157 ZFPL1 MARCHF5 TRIM8 MGRN1	4.83e-05	326	171	12	IPR001841
Domain	-	VWF SVEP1 ANTXRL SEC24C SEC23B SEC23A	5.97e-05	74	171	6	3.40.50.410
Domain	Ephrin_rec_like	EPHB2 SVEP1 TG	1.18e-04	11	171	3	PF07699
Domain	RING	UBR2 ZMYND11 RNF166 MKRN2 COP1 G2E3 TRIM3 RNF157 ZFPL1 TRIM8 MGRN1	1.20e-04	305	171	11	SM00184
Domain	TILa_dom	ZAN TECTA	2.49e-04	3	171	2	IPR025615
Domain	Serum_albumin/AFP/Afamin	AFM ALB	2.49e-04	3	171	2	IPR021177
Domain	TILa	ZAN TECTA	2.49e-04	3	171	2	PF12714
Domain	-	RASA4 RASA4B	2.49e-04	3	171	2	4.10.1130.10
Domain	IQSEC_PH	IQSEC2 IQSEC1	2.49e-04	3	171	2	IPR033742
Domain	IQ_SEC7_PH	IQSEC2 IQSEC1	2.49e-04	3	171	2	PF16453
Domain	FBN	FBN1 FBN3	2.49e-04	3	171	2	IPR011398
Domain	Gelsolin	SEC24C SEC23B SEC23A	2.55e-04	14	171	3	PF00626
Domain	Gelsolin-like_dom	SEC24C SEC23B SEC23A	2.55e-04	14	171	3	IPR007123
Domain	VWFC_1	VWF ZAN MUC5B CHRD	3.18e-04	36	171	4	PS01208
Domain	ALBUMIN	AFM ALB	4.94e-04	4	171	2	SM00103
Domain	Serum_albumin_N	AFM ALB	4.94e-04	4	171	2	IPR014760
Domain	Serum_albumin_CS	AFM ALB	4.94e-04	4	171	2	IPR020857
Domain	ALBUMIN_2	AFM ALB	4.94e-04	4	171	2	PS51438
Domain	ALBUMIN_1	AFM ALB	4.94e-04	4	171	2	PS00212
Domain	Serum_albumin	AFM ALB	4.94e-04	4	171	2	PF00273
Domain	CTCK_1	VWF MUC5B SLIT3	5.56e-04	18	171	3	PS01185
Domain	CONNEXINS_1	GJD2 GJA9 GJA10	6.56e-04	19	171	3	PS00407
Domain	Connexin	GJD2 GJA9 GJA10	7.67e-04	20	171	3	IPR000500
Domain	Connexin_CCC	GJD2 GJA9 GJA10	7.67e-04	20	171	3	IPR019570
Domain	Connexin_N	GJD2 GJA9 GJA10	7.67e-04	20	171	3	IPR013092
Domain	Connexin_CCC	GJD2 GJA9 GJA10	7.67e-04	20	171	3	SM01089
Domain	CONNEXINS_2	GJD2 GJA9 GJA10	7.67e-04	20	171	3	PS00408
Domain	Connexin	GJD2 GJA9 GJA10	7.67e-04	20	171	3	PF00029
Domain	Connexin_CS	GJD2 GJA9 GJA10	7.67e-04	20	171	3	IPR017990
Domain	CNX	GJD2 GJA9 GJA10	7.67e-04	20	171	3	SM00037
Domain	Musac_Ach_rcpt	CHRM2 CHRM5	8.18e-04	5	171	2	IPR000995
Domain	Serum_albumin-like	AFM ALB	8.18e-04	5	171	2	IPR020858
Domain	HnRNP-L/PTB	PTBP2 PTBP1	8.18e-04	5	171	2	IPR006536
Domain	VWFA	ITGA11 VWF SVEP1 ANTXRL HMCN2	9.38e-04	82	171	5	PS50234
Domain	CT	VWF MUC5B SLIT3	1.02e-03	22	171	3	SM00041
Domain	VWA	ITGA11 VWF SVEP1 ANTXRL HMCN2	1.05e-03	84	171	5	SM00327
Domain	zf-C3HC4	RNF166 MKRN2 COP1 TRIM3 RNF157 MARCHF5 TRIM8 MGRN1	1.06e-03	223	171	8	PF00097
Domain	PH	CDC42BPA ARHGEF5 IQSEC2 RASA4 IQSEC1 RASA4B AGAP7P AGAP4 AGAP6	1.08e-03	278	171	9	SM00233
Domain	PH_DOMAIN	CDC42BPA ARHGEF5 IQSEC2 RASA4 IQSEC1 RASA4B AGAP7P AGAP4 AGAP6	1.10e-03	279	171	9	PS50003
Domain	PH_domain	CDC42BPA ARHGEF5 IQSEC2 RASA4 IQSEC1 RASA4B AGAP7P AGAP4 AGAP6	1.13e-03	280	171	9	IPR001849
Domain	ALB/AFP/VDB	AFM ALB	1.22e-03	6	171	2	IPR000264
Domain	-	SEC24C SEC23B SEC23A	1.32e-03	24	171	3	3.40.20.10
Domain	Keratin_2_head	KRT81 KRT83 KRT86	1.32e-03	24	171	3	IPR032444
Domain	ADF-H/Gelsolin-like_dom	SEC24C SEC23B SEC23A	1.32e-03	24	171	3	IPR029006
Domain	Keratin_2_head	KRT81 KRT83 KRT86	1.32e-03	24	171	3	PF16208
Domain	ZF_RING_1	UBR2 RNF166 MKRN2 COP1 TRIM3 RNF157 ZFPL1 TRIM8 MGRN1	1.48e-03	291	171	9	PS00518
Domain	Ephrin_rec_like	EPHB2 SVEP1 TG	1.50e-03	25	171	3	SM01411
Domain	Tyr-kin_ephrin_A/B_rcpt-like	EPHB2 SVEP1 TG	1.50e-03	25	171	3	IPR011641
Domain	Cys_knot_C	VWF MUC5B SLIT3	1.50e-03	25	171	3	IPR006207
Domain	CTCK_2	VWF MUC5B SLIT3	1.50e-03	25	171	3	PS01225
Domain	Keratin_II	KRT81 KRT83 KRT86	1.68e-03	26	171	3	IPR003054
Domain	TB	FBN1 FBN3	1.70e-03	7	171	2	PF00683
Domain	VWA	ITGA11 VWF SVEP1 ANTXRL	1.72e-03	56	171	4	PF00092
Domain	ZF_RING_2	UBR2 RNF166 MKRN2 COP1 TRIM3 RNF157 ZFPL1 TRIM8 MGRN1	1.74e-03	298	171	9	PS50089
Domain	hEGF	SVEP1 FBN3 NOTCH2	2.09e-03	28	171	3	PF12661
Pubmed	MBD3L1 and MBD3L2, two new proteins homologous to the methyl-CpG-binding proteins MBD2 and MBD3: characterization of MBD3L1 as a testis-specific transcriptional repressor.	MBD3L5 MBD3L2 MBD3L3 MBD3L4 MBD3L2B	1.93e-11	6	177	5	12504854
Pubmed	Haploid male germ cell- and oocyte-specific Mbd3l1 and Mbd3l2 genes are dispensable for early development, fertility, and zygotic DNA demethylation in the mouse.	MBD3L5 MBD3L2 MBD3L3 MBD3L4 MBD3L2B	1.93e-11	6	177	5	18942147
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	RALGDS ABCA2 CDC42BPA USP28 CECR2 DIDO1 G2E3 ADNP MTA3 SEMA5B HPS4 SLIT3 NCAPD2 HMGXB3 AGAP7P ESPL1 AGAP4 AGAP6 MGRN1	3.55e-11	529	177	19	14621295
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ZNF821 ABCA2 VWF MCHR1 DIS3L USP28 KRT83 IQSEC2 ZNF521 LAMB1 ABCC5 XPC AIP TARS3 FBN1 EFEMP1 MTA3 HPS4 TRIM8 LRP2 RORB PLAUR IFT122 ANKRD36 TNKS2 BTRC RECK ZNF292	8.94e-11	1285	177	28	35914814
Pubmed	MBD3L2 interacts with MBD3 and components of the NuRD complex and can oppose MBD2-MeCP1-mediated methylation silencing.	MBD3L5 MBD3L2 MBD3L3 MBD3L4 MBD3L2B	9.30e-09	15	177	5	15701600
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	EPHB2 UBR2 TMEM67 ITGA11 ABCA2 ERAP1 ADAM15 HS6ST2 LAMB1 AIP LDLR TGFB2 CLPTM1L FBN1 EFEMP1 SEC24C TMPO ADGRE5 PLAUR ALDH3A2 NOTCH2 PCSK9 MGRN1	5.38e-08	1201	177	23	35696571
Pubmed	Novel KRT83 and KRT86 mutations associated with monilethrix.	KRT81 KRT83 KRT86	1.30e-07	3	177	3	25557232
Pubmed	Structure and site of expression of a murine type II hair keratin.	KRT81 KRT83 KRT86	1.30e-07	3	177	3	1372089
Pubmed	Transient expression of mouse hair keratins in transfected HeLa cells: interactions between "hard" and "soft" keratins.	KRT81 KRT83 KRT86	1.30e-07	3	177	3	1712823
Pubmed	AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release.	CHRM5 AGAP7P AGAP4 AGAP6	1.33e-07	10	177	4	20664521
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	EPHB2 FNDC3B ZMYND11 IQSEC2 INTS1 XPC PTBP1 LDLR ZFPL1 AAR2 CLPTM1L PELP1 MARCHF5 CCNL1 NCAPD2 TMEM209 IQSEC1 MFN2 TMPO LOXL4 ALDH3A2 NOTCH2	2.36e-07	1203	177	22	29180619
Pubmed	Expression of connexin genes in the human retina.	GJD2 GJA9 GJA10	5.16e-07	4	177	3	20979653
Pubmed	Keratins of the human hair follicle.	KRT81 KRT83 KRT86	5.16e-07	4	177	3	15797458
Pubmed	Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c.	VWF ADAM15 LAMB1 LDLR SVEP1 TGFB2 FBN1 EFEMP1 SLIT3 PCSK9	6.43e-07	248	177	10	24006456
Pubmed	TGFβ attenuates cartilage extracellular matrix degradation via enhancing FBXO6-mediated MMP14 ubiquitination.	ABCA2 ERAP1 ADAM15 LAMB1 MUC5B LDLR TGFB2 ALB	2.13e-06	164	177	8	32409323
Pubmed	A family of mammalian proteins homologous to yeast Sec24p.	SEC24C SEC23B SEC23A	2.56e-06	6	177	3	10329445
Pubmed	Sec24 proteins and sorting at the endoplasmic reticulum.	SEC24C SEC23B SEC23A	2.56e-06	6	177	3	10075675
Pubmed	Integrative predictive model of coronary artery calcification in atherosclerosis.	TPO VWF TLR7 LDLR THBD EFEMP1 AGTR1 SCNN1B PCSK9	2.92e-06	229	177	9	19948975
Pubmed	Comparative genome mapping in the sequence-based era: early experience with human chromosome 7.	ARHGEF5 RASA4 RASA4B	7.12e-06	8	177	3	10810084
Pubmed	GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins.	AGAP7P AGAP4 AGAP6	1.06e-05	9	177	3	12640130
Pubmed	Hemostatic gene polymorphisms in young Sardinian with non-fatal acute myocardial infarction.	TPO VWF THBD	1.51e-05	10	177	3	20036902
Pubmed	Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	ERAP1 IQSEC2 RASA4 PACS2 ZNF292 MGRN1	1.69e-05	105	177	6	9628581
Pubmed	AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase.	AGAP7P AGAP4 AGAP6	2.08e-05	11	177	3	15381706
Pubmed	Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization.	PTBP2 PTBP1 ALB BTRC	2.09e-05	32	177	4	36252997
Pubmed	Patients With LDLR and PCSK9 Gene Variants Experienced Higher Incidence of Cardiovascular Outcomes in Heterozygous Familial Hypercholesterolemia.	LDLR PCSK9	2.58e-05	2	177	2	33533259
Pubmed	Effect of diet and genotype on the miRNome of mice with altered lipoprotein metabolism.	LDLR PCSK9	2.58e-05	2	177	2	37664585
Pubmed	PCSK9 acts as a chaperone for the LDL receptor in the endoplasmic reticulum.	LDLR PCSK9	2.58e-05	2	177	2	24144304
Pubmed	Mice Fed a High-Cholesterol Diet Supplemented with Quercetin-3-Glucoside Show Attenuated Hyperlipidemia and Hyperinsulinemia Associated with Differential Regulation of PCSK9 and LDLR in their Liver and Pancreas.	LDLR PCSK9	2.58e-05	2	177	2	29396908
Pubmed	Antagonism of secreted PCSK9 increases low density lipoprotein receptor expression in HepG2 cells.	LDLR PCSK9	2.58e-05	2	177	2	19224862
Pubmed	Serum proprotein convertase subtilisin/kexin type 9 and cell surface low-density lipoprotein receptor: evidence for a reciprocal regulation.	LDLR PCSK9	2.58e-05	2	177	2	23690465
Pubmed	Hypercholesterolemia Induced by a PCSK9 Gain-of-Function Mutation Augments Angiotensin II-Induced Abdominal Aortic Aneurysms in C57BL/6 Mice-Brief Report.	LDLR PCSK9	2.58e-05	2	177	2	27470509
Pubmed	Binding to the low-density lipoprotein receptor accelerates futile catalytic cycling in PCSK9 and raises the equilibrium level of intramolecular acylenzyme.	LDLR PCSK9	2.58e-05	2	177	2	19222187
Pubmed	New PCSK9 inhibitor miR-552-3p reduces LDL-C via enhancing LDLR in high fat diet-fed mice.	LDLR PCSK9	2.58e-05	2	177	2	33737240
Pubmed	Hepatic Overexpression of Soluble Urokinase Receptor (uPAR) Suppresses Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (LDLR-/-) Mice.	LDLR PLAUR	2.58e-05	2	177	2	26313756
Pubmed	Having excess levels of PCSK9 is not sufficient to induce complex formation between PCSK9 and the LDL receptor.	LDLR PCSK9	2.58e-05	2	177	2	24486405
Pubmed	Macrophage ABCA2 deletion modulates intracellular cholesterol deposition, affects macrophage apoptosis, and decreases early atherosclerosis in LDL receptor knockout mice.	ABCA2 LDLR	2.58e-05	2	177	2	22748276
Pubmed	CAPRI regulates Ca(2+)-dependent inactivation of the Ras-MAPK pathway.	RASA4 RASA4B	2.58e-05	2	177	2	11448776
Pubmed	Urokinase-type plasminogen activator receptor is required for impairing toll-like receptor 7 signaling on macrophage efferocytosis in lupus.	TLR7 PLAUR	2.58e-05	2	177	2	32911323
Pubmed	Structural requirements for PCSK9-mediated degradation of the low-density lipoprotein receptor.	LDLR PCSK9	2.58e-05	2	177	2	18753623
Pubmed	PCSK9 and LDLR degradation: regulatory mechanisms in circulation and in cells.	LDLR PCSK9	2.58e-05	2	177	2	25110901
Pubmed	A missense mutation in the type II hair keratin hHb3 is associated with monilethrix.	KRT83 KRT86	2.58e-05	2	177	2	15744029
Pubmed	Thrombomodulin and von Willebrand factor: relation to endothelial dysfunction and disease outcome in children with acute lymphoblastic leukemia.	VWF THBD	2.58e-05	2	177	2	21150180
Pubmed	Characterization of LDLR rs5925 and PCSK9 rs505151 genetic variants frequencies in healthy subjects from northern Chile: Influence on plasma lipid levels.	LDLR PCSK9	2.58e-05	2	177	2	31441123
Pubmed	Elevated Thyroid Autoantibodies Aggravate Stroke Severity in Euthyroidism with Acute Ischemic Stroke.	TPO TG	2.58e-05	2	177	2	35256895
Pubmed	Cloning and functional characterization of mammalian homologues of the COPII component Sec23.	SEC23B SEC23A	2.58e-05	2	177	2	8898360
Pubmed	Potentiating CD8+ T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling.	LDLR PCSK9	2.58e-05	2	177	2	33606190
Pubmed	Effect of a splice site mutation in LDLR gene and two variations in PCSK9 gene in Tunisian families with familial hypercholesterolaemia.	LDLR PCSK9	2.58e-05	2	177	2	21115573
Pubmed	Megalin/gp330 mediates uptake of albumin in renal proximal tubule.	LRP2 ALB	2.58e-05	2	177	2	8898021
Pubmed	Loss- and gain-of-function PCSK9 variants: cleavage specificity, dominant negative effects, and low density lipoprotein receptor (LDLR) degradation.	LDLR PCSK9	2.58e-05	2	177	2	22875854
Pubmed	LDLR and PCSK9 Are Associated with the Presence of Antiphospholipid Antibodies and the Development of Thrombosis in aPLA Carriers.	LDLR PCSK9	2.58e-05	2	177	2	26820623
Pubmed	Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation.	LDLR PCSK9	2.58e-05	2	177	2	17452316
Pubmed	PCSK9-mediated degradation of the LDL receptor generates a 17 kDa C-terminal LDL receptor fragment.	LDLR PCSK9	2.58e-05	2	177	2	23509406
Pubmed	Impact of LDLR and PCSK9 pathogenic variants in Japanese heterozygous familial hypercholesterolemia patients.	LDLR PCSK9	2.58e-05	2	177	2	31491741
Pubmed	Blood lipid-related low-frequency variants in LDLR and PCSK9 are associated with onset age and risk of myocardial infarction in Japanese.	LDLR PCSK9	2.58e-05	2	177	2	29802317
Pubmed	Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Single Domain Antibodies Are Potent Inhibitors of Low Density Lipoprotein Receptor Degradation.	LDLR PCSK9	2.58e-05	2	177	2	27284008
Pubmed	Role of ubiquitination in PCSK9-mediated low-density lipoprotein receptor degradation.	LDLR PCSK9	2.58e-05	2	177	2	22074827
Pubmed	Prognostic value of plasma levels of thrombomodulin and von Willebrand factor in Egyptian children with acute lymphoblastic leukemia.	VWF THBD	2.58e-05	2	177	2	24243921
Pubmed	A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates.	LDLR PCSK9	2.58e-05	2	177	2	19443683
Pubmed	Low density lipoprotein binds to proprotein convertase subtilisin/kexin type-9 (PCSK9) in human plasma and inhibits PCSK9-mediated low density lipoprotein receptor degradation.	LDLR PCSK9	2.58e-05	2	177	2	23400816
Pubmed	Contribution of mucus concentration and secreted mucins Muc5ac and Muc5b to the pathogenesis of muco-obstructive lung disease.	MUC5B SCNN1B	2.58e-05	2	177	2	28435155
Pubmed	Heparan sulfate proteoglycans present PCSK9 to the LDL receptor.	LDLR PCSK9	2.58e-05	2	177	2	28894089
Pubmed	Functions of the COPII gene paralogs SEC23A and SEC23B are interchangeable in vivo.	SEC23B SEC23A	2.58e-05	2	177	2	30065114
Pubmed	Identification of amino acid residues in the ligand binding repeats of LDL receptor important for PCSK9 binding.	LDLR PCSK9	2.58e-05	2	177	2	30617148
Pubmed	Molecular basis for LDL receptor recognition by PCSK9.	LDLR PCSK9	2.58e-05	2	177	2	18250299
Pubmed	Non-hematopoietic deficiency of proprotein convertase subtilisin/kexin type 9 deficiency leads to more severe anemia in a murine model of sickle cell disease.	LDLR PCSK9	2.58e-05	2	177	2	33020528
Pubmed	Mutations in the genes for thyroglobulin and thyroid peroxidase cause thyroid dyshormonogenesis and autosomal-recessive intellectual disability.	TPO TG	2.58e-05	2	177	2	27305979
Pubmed	Using genetic variants to evaluate the causal effect of cholesterol lowering on head and neck cancer risk: A Mendelian randomization study.	LDLR PCSK9	2.58e-05	2	177	2	33886544
Pubmed	Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes.	TPO TG	2.58e-05	2	177	2	10487692
Pubmed	MITOL deletion in the brain impairs mitochondrial structure and ER tethering leading to oxidative stress.	MARCHF5 MFN2	2.58e-05	2	177	2	31416892
Pubmed	Regional variation in aortic AT1b receptor mRNA abundance is associated with contractility but unrelated to atherosclerosis and aortic aneurysms.	LDLR AGTR1	2.58e-05	2	177	2	23119030
Pubmed	A variable monilethrix phenotype associated with a novel mutation, Glu402Lys, in the helix termination motif of the type II hair keratin hHb1.	KRT81 KRT86	2.58e-05	2	177	2	9665406
Pubmed	Streamlined platform for short hairpin RNA interference and transgenesis in cultured mammalian cells.	PTBP2 PTBP1	2.58e-05	2	177	2	21768390
Pubmed	Kynurenines and oxidative status are independently associated with thrombomodulin and von Willebrand factor levels in patients with end-stage renal disease.	VWF THBD	2.58e-05	2	177	2	19477487
Pubmed	Silencing of hHS6ST2 inhibits progression of pancreatic cancer through inhibition of Notch signalling.	HS6ST2 NOTCH2	2.58e-05	2	177	2	21443520
Pubmed	Proprotein convertase subtilisin/kexin type 9 targets megalin in the kidney proximal tubule and aggravates proteinuria in nephrotic syndrome.	LRP2 PCSK9	2.58e-05	2	177	2	37406929
Pubmed	β-Estradiol results in a proprotein convertase subtilisin/kexin type 9-dependent increase in low-density lipoprotein receptor levels in human hepatic HuH7 cells.	LDLR PCSK9	2.58e-05	2	177	2	25913303
Pubmed	Genetic Variants of LDLR and PCSK9 Associated with Variations in Response to Antihypercholesterolemic Effects of Armolipid Plus with Berberine.	LDLR PCSK9	2.58e-05	2	177	2	27015087
Pubmed	Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm.	TGFB2 FBN1	2.58e-05	2	177	2	22772368
Pubmed	Roles of the low density lipoprotein receptor and related receptors in inhibition of lipoprotein(a) internalization by proprotein convertase subtilisin/kexin type 9.	LDLR PCSK9	2.58e-05	2	177	2	28750079
Pubmed	A new mutation in the type II hair cortex keratin hHb1 involved in the inherited hair disorder monilethrix.	KRT81 KRT86	2.58e-05	2	177	2	9402962
Pubmed	Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice.	LDLR AGTR1	2.58e-05	2	177	2	18274671
Pubmed	The M2 module of the Cys-His-rich domain (CHRD) of PCSK9 protein is needed for the extracellular low-density lipoprotein receptor (LDLR) degradation pathway.	LDLR PCSK9	2.58e-05	2	177	2	23105118
Pubmed	Patterns and tempo of PCSK9 pseudogenizations suggest an ancient divergence in mammalian cholesterol homeostasis mechanisms.	LDLR PCSK9	2.58e-05	2	177	2	33515402
Pubmed	PCSK9-D374Y Suppresses Hepatocyte Migration through Downregulating Free Cholesterol Efflux Rate and Activity of Extracellular Signal-Regulated Kinase.	LDLR PCSK9	2.58e-05	2	177	2	36655117
Pubmed	Screening of PCSK9 and LDLR genetic variants in Familial Hypercholesterolemia (FH) patients in India.	LDLR PCSK9	2.58e-05	2	177	2	33864011
Pubmed	In Silico Insights into Protein-protein Interaction Disruptive Mutations in the PCSK9-LDLR complex.	LDLR PCSK9	2.58e-05	2	177	2	32106405
Pubmed	Mechanistic implications for LDL receptor degradation from the PCSK9/LDLR structure at neutral pH.	LDLR PCSK9	2.58e-05	2	177	2	22081141
Pubmed	Alternative splicing of brain-specific PTB defines a tissue-specific isoform pattern that predicts distinct functional roles.	PTBP2 PTBP1	2.58e-05	2	177	2	12213192
Pubmed	Low-density lipoprotein (LDL)-dependent uptake of Gram-positive lipoteichoic acid and Gram-negative lipopolysaccharide occurs through LDL receptor.	LDLR PCSK9	2.58e-05	2	177	2	30002483
Pubmed	PTBP1 and PTBP2 Repress Nonconserved Cryptic Exons.	PTBP2 PTBP1	2.58e-05	2	177	2	27681424
Pubmed	Proprotein convertase subtilisin/kexin 9 V4I variant with LDLR mutations modifies the phenotype of familial hypercholesterolemia.	LDLR PCSK9	2.58e-05	2	177	2	27206942
Pubmed	A Therapeutic Peptide Vaccine Against PCSK9.	LDLR PCSK9	2.58e-05	2	177	2	28970592
Pubmed	PCSK9 deficiency results in a specific shedding of excess LDLR in female mice only: Role of hepatic cholesterol.	LDLR PCSK9	2.58e-05	2	177	2	35985474
Pubmed	Deletion of AT1a (Angiotensin II Type 1a) Receptor or Inhibition of Angiotensinogen Synthesis Attenuates Thoracic Aortopathies in Fibrillin1C1041G/+ Mice.	FBN1 AGTR1	2.58e-05	2	177	2	34407634
Pubmed	A new class of endoplasmic reticulum export signal PhiXPhiXPhi for transmembrane proteins and its selective interaction with Sec24C.	SEC24C SEC23A	2.58e-05	2	177	2	23658022
Pubmed	A proprotein convertase subtilisin-like/kexin type 9 (PCSK9) C-terminal domain antibody antigen-binding fragment inhibits PCSK9 internalization and restores low density lipoprotein uptake.	LDLR PCSK9	2.58e-05	2	177	2	20172854
Pubmed	Antisense inhibition of proprotein convertase subtilisin/kexin type 9 reduces serum LDL in hyperlipidemic mice.	LDLR PCSK9	2.58e-05	2	177	2	17242417
Pubmed	Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia.	LDLR PCSK9	2.58e-05	2	177	2	16183066
Pubmed	A locked nucleic acid antisense oligonucleotide (LNA) silences PCSK9 and enhances LDLR expression in vitro and in vivo.	LDLR PCSK9	2.58e-05	2	177	2	20498851
Pubmed	The cellular trafficking of the secretory proprotein convertase PCSK9 and its dependence on the LDLR.	LDLR PCSK9	2.58e-05	2	177	2	17461796
Interaction	IGFL3 interactions	TMEM67 LAMB1 ATE1 LDLR LRP2 NOTCH2 MGRN1	3.42e-06	75	171	7	int:IGFL3
Interaction	ZFP41 interactions	KBTBD6 LDLR KBTBD7 FBN1 LRP2 NOTCH2	8.67e-06	57	171	6	int:ZFP41
Interaction	GREM2 interactions	KBTBD6 LDLR KBTBD7 LRP2 NOTCH2	1.45e-05	37	171	5	int:GREM2
Cytoband	10q24.3	TRIM8 ALDH18A1	2.19e-04	6	177	2	10q24.3
Cytoband	19p13.2	MBD3L5 MBD3L2 MBD3L3 MBD3L4 LDLR MBD3L2B	2.78e-04	229	177	6	19p13.2
Cytoband	7q22	ZAN LAMB1 RASA4	4.30e-04	38	177	3	7q22
GeneFamily	Gap junction proteins	GJD2 GJA9 GJA10	4.10e-04	22	121	3	314
GeneFamily	Cholinergic receptors muscarinic	CHRM2 CHRM5	4.38e-04	5	121	2	180
GeneFamily	Ring finger proteins	RNF166 MKRN2 COP1 TRIM3 RNF157 MARCHF5 TRIM8 MGRN1	5.29e-04	275	121	8	58
GeneFamily	Keratins, type II	KRT81 KRT83 KRT86	7.61e-04	27	121	3	609
GeneFamily	Fibulins	EFEMP1 HMCN2	1.21e-03	8	121	2	556
GeneFamily	ArfGAPs	AGAP7P AGAP4 AGAP6	1.38e-03	33	121	3	395
GeneFamily	Pleckstrin homology domain containing\|SH2 domain containing\|C2 and RasGAP domain containing	RASA4 RASA4B	1.93e-03	10	121	2	830
GeneFamily	Low density lipoprotein receptors	LDLR LRP2	3.30e-03	13	121	2	634
GeneFamily	Integrator complex	INTS7 INTS1	4.41e-03	15	121	2	1366
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ADNP ZFHX4	4.41e-03	15	121	2	529
GeneFamily	X-linked mental retardation\|Rho GTPase activating proteins\|BAR-PH domain containing	AGAP4 AGAP6	5.66e-03	17	121	2	1291
GeneFamily	Ankyrin repeat domain containing	ANKRD36 AGAP7P TNKS2 AGAP4 AGAP6 NOTCH2	5.78e-03	242	121	6	403
Coexpression	NABA_ECM_GLYCOPROTEINS	VWF LAMB1 TECTA SVEP1 FBN1 EFEMP1 HMCN2 OTOGL SLIT3	5.84e-06	191	175	9	MM17059
Coexpression	NABA_ECM_GLYCOPROTEINS	VWF LAMB1 TECTA SVEP1 FBN1 EFEMP1 HMCN2 SLIT3 FBN3	7.20e-06	196	175	9	M3008
Coexpression	GSE7768_OVA_WITH_LPS_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN	TMEM67 HMCN2 ZC2HC1A RASA4 MARCHF5 CCNL1 PLAUR NOTCH2	1.97e-05	170	175	8	M6855
ToppCell	Bronchus_Control_(B.)-Stromal-TX\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	ITGA11 ZNF521 LAMB1 GFRA1 SVEP1 FBN1 ZFHX4 AGTR1 CHRD	1.08e-07	200	176	9	69b41f5fb370aa8840a9ad7919d03ef1e57d1b5b
ToppCell	Control_saline-Endothelial-Endothelial-Vein\|Control_saline / Treatment groups by lineage, cell group, cell type	FNDC3B GPR4 VWF ADAM15 ZNF521 NR2F2 THBD FBN1 RASA4	1.08e-07	200	176	9	e5f876910bc8cb390d9b46a48d9b6d4d57235551
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CECR2 MUC5B TECTA SVEP1 ZFHX4 PIK3C2G MOV10L1 LRP2	2.51e-07	160	176	8	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CECR2 MUC5B TECTA SVEP1 ZFHX4 PIK3C2G MOV10L1 LRP2	2.51e-07	160	176	8	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	metastatic_Brain-Fibroblasts-Myofibroblasts\|metastatic_Brain / Location, Cell class and cell subclass	ITGA11 ZNF521 LAMB1 SVEP1 FBN1 PTPRN SLIT3 IGFL2	6.42e-07	181	176	8	bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9
ToppCell	5'-Adult-LymphNode-Endothelial-blood_vessel_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GPR4 VWF ADAM15 THBD MCTP1 RASA4 ADAMTS18 RASA4B	9.26e-07	190	176	8	141266bf411ea675fbf889b20c1b08673c45ff95
ToppCell	facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FNDC3B ITGA11 LAMB1 GFRA1 SVEP1 FBN1 CHRD RECK	1.00e-06	192	176	8	671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5
ToppCell	facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FNDC3B ITGA11 LAMB1 GFRA1 SVEP1 FBN1 CHRD RECK	1.00e-06	192	176	8	840a34c1b82d218be999ab5e1bcafd6370d7a4b1
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RAMP1 LAMB1 CHRM2 GFRA1 SVEP1 EFEMP1 HMCN2 ZFHX4	1.00e-06	192	176	8	20ede290e01ad574afd122d72b59dbc52c595fad
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 LAMB1 GFRA1 SVEP1 FBN1 ZFHX4 AGTR1 SLIT3	1.04e-06	193	176	8	c8c21eee8c6c086dc2faf416669cd4a002870fbe
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 LAMB1 GFRA1 SVEP1 FBN1 ZFHX4 AGTR1 SLIT3	1.04e-06	193	176	8	5b602b1702283184bd3943c2a6f2290b7c37e407
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 GFRA1 NR2F2 SVEP1 FBN1 ZFHX4 AGTR1 SLIT3	1.13e-06	195	176	8	cad6563cc51d212554152c727fc2c249c6a07e4d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 GFRA1 NR2F2 SVEP1 FBN1 ZFHX4 AGTR1 SLIT3	1.13e-06	195	176	8	783bfa8110161cbd6def50ce849cae676c39c458
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 RAMP1 NR2F2 SVEP1 FBN1 AGTR1 SLIT3 ADGRE5	1.17e-06	196	176	8	a12dd986df65c36f248cf10815c3b8b6238613b0
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 RAMP1 GFRA1 NR2F2 SVEP1 FBN1 AGTR1 SLIT3	1.17e-06	196	176	8	ba869f7a86f37fd6d84d6ad69baca0e0faaf5887
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 RAMP1 GFRA1 NR2F2 SVEP1 FBN1 AGTR1 SLIT3	1.17e-06	196	176	8	30ad56d49000e4ddce73b4443b3994564bd1e2d6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 LAMB1 GFRA1 SVEP1 FBN1 ZFHX4 AGTR1 SLIT3	1.17e-06	196	176	8	3a6c942e2907aa07b5e12dbf9019d18f7bfca507
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 RAMP1 NR2F2 SVEP1 FBN1 AGTR1 SLIT3 ADGRE5	1.17e-06	196	176	8	3e6803587d8566fd08cb8b290be3b6461743d79c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 LAMB1 GFRA1 SVEP1 FBN1 ZFHX4 AGTR1 SLIT3	1.17e-06	196	176	8	bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 GFRA1 NR2F2 SVEP1 FBN1 ZFHX4 AGTR1 SLIT3	1.22e-06	197	176	8	ae0435f4b4a9cdedb1c201fc56921048390097bf
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 GFRA1 NR2F2 SVEP1 FBN1 ZFHX4 AGTR1 SLIT3	1.22e-06	197	176	8	37f6b6f2809b952382eaebb642b0aad6371f4251
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 RAMP1 NR2F2 SVEP1 FBN1 AGTR1 SLIT3 ADGRE5	1.22e-06	197	176	8	80e153790cef37b743e22a7370ff5b3a6abf147d
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	UBR2 RTTN IFI44 HELB CCNL1 ANKRD36 UTY ZNF292	1.31e-06	199	176	8	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ITGA11 ZNF521 LAMB1 GFRA1 SVEP1 FBN1 ZFHX4 SLIT3	1.31e-06	199	176	8	abd6117f8a3d7e798d8471c16d97b34aaf50fc9c
ToppCell	Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	ITGA11 ZNF521 GFRA1 SVEP1 FBN1 ZFHX4 AGTR1 CHRD	1.36e-06	200	176	8	2022df85df94ab8cbb4e80e3fe9894c01051c5e0
ToppCell	Ionocyte-iono-1\|World / Class top	ZNF521 FANCM TEKT5 ADHFE1 RASA4 SCNN1B EDRF1	5.03e-06	169	176	7	4b68bcb4b5fc3cd2db23cd4edace7444aa2d605c
ToppCell	tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs\|Fibroblasts / Location, Cell class and cell subclass	XPC GFRA1 SVEP1 ADHFE1 AGTR1 TMPO ZNF292	5.03e-06	169	176	7	84b898a9fd8ced67c6a501d5cef6416f519902c4
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 RAMP1 GFRA1 SVEP1 FBN1 ZFHX4 SLIT3	6.81e-06	177	176	7	b872ee91e01265b101b81bd304cf6b95d5419e68
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMB1 CHRM2 NR2F2 OTOGL AGTR1 SLIT3 CHRD	7.33e-06	179	176	7	dc6cd46fa652b296ddbc41855f6377946d0a4cdc
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 RAMP1 GFRA1 SVEP1 FBN1 SLIT3 CHRD	8.17e-06	182	176	7	b7d532feb73167e05475855061b35a209583f44c
ToppCell	5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWF ZAN ADAM15 ZNF521 THBD FBN1 MCTP1	8.17e-06	182	176	7	d0e3663f7d39f22a3ebd7fde56ab3504773598f4
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CHRM2 NR2F2 SVEP1 TGFB2 ADGRE5 FBN3 NOTCH2	8.17e-06	182	176	7	d3a037268f026eb2f84428b1821022503cef7756
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	EPHB2 TPO ITGA11 TECTA MCTP1 SEMA5B SLIT3	8.17e-06	182	176	7	72e65a23cd36085bc880087d3cae92395de918a1
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 RAMP1 GFRA1 SVEP1 FBN1 SLIT3 CHRD	8.17e-06	182	176	7	af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	EPHB2 TPO ITGA11 TECTA MCTP1 SEMA5B SLIT3	8.17e-06	182	176	7	05c167158815bf25d509df59ab386e1990712765
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBX15 ITGA11 SVEP1 THBD FBN1 EFEMP1 SLIT3	8.47e-06	183	176	7	5cfcd589a480e67654d3d94e71916f122150db10
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBX15 ITGA11 SVEP1 THBD FBN1 EFEMP1 SLIT3	8.47e-06	183	176	7	c3ea8d3b916ffcaca3156e0d77a952724554c4ab
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBX15 ITGA11 SVEP1 THBD FBN1 EFEMP1 SLIT3	8.47e-06	183	176	7	81003ddc24164959dd41bb12fcac72638789b8f2
ToppCell	CF-Myeloid-Neutrophil\|CF / Disease state, Lineage and Cell class	FNDC3B FBXL13 LITAF FBXL5 TG MCTP1 PLAUR	8.47e-06	183	176	7	da43827952e6fdee2ce94648c316182f272b321c
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D122\|Adult / Lineage, Cell type, age group and donor	ITGA11 ZNF521 GFRA1 SVEP1 FBN1 SLIT3 CHRD	8.77e-06	184	176	7	2b7e6f91e11c228f0521e099886867d9e998e78d
ToppCell	5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NR2F2 FBN1 EFEMP1 ZFHX4 SEMA5B AGTR1 SLIT3	8.77e-06	184	176	7	4d4d8f3f44c67d74c57e7af7b7c158f0157b2f49
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CHRM2 NR2F2 SVEP1 TGFB2 EFEMP1 ADGRE5 FBN3	9.09e-06	185	176	7	0b5a0df58ae2ad8261f40f152775747af4f3937a
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-24m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA11 RAMP1 SVEP1 THBD FBN1 EFEMP1 SLIT3	9.41e-06	186	176	7	ff6ccfdf2509f96caa10281c29a95b432f6c6dcc
ToppCell	COVID-19-kidney-Fibroblast-1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ITGA11 GFRA1 NR2F2 SVEP1 ZFHX4 AGTR1 SLIT3	9.75e-06	187	176	7	76bfe8c42430a230a8bdf299575c444fb7780f24
ToppCell	droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMB1 SVEP1 FBN1 EFEMP1 SLIT3 LRP2 LOXL4	9.75e-06	187	176	7	4e553721fa5598cb211f44e3226280b7e6885484
ToppCell	droplet-Pancreas-Exocrine-18m-Mesenchymal\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMB1 SVEP1 FBN1 EFEMP1 SLIT3 LRP2 LOXL4	9.75e-06	187	176	7	d36e7fc6125e7a4310499365022d38f34b757a73
ToppCell	droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMB1 SVEP1 FBN1 EFEMP1 SLIT3 LRP2 LOXL4	9.75e-06	187	176	7	827eae63fabf6892a82ce7779b5f395958d3d628
ToppCell	3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GPR4 VWF ADAM15 ZNF521 NR2F2 THBD ADAMTS18	9.75e-06	187	176	7	d6765854154557794815514c0aa355bc74b8523e
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	ZNF521 LAMB1 CHRM2 GFRA1 SVEP1 FBN1 SLIT3	9.75e-06	187	176	7	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	COVID-19_Convalescent-Classical_Monocyte-cMono_3\|COVID-19_Convalescent / Disease condition and Cell class	ZMYND11 FLT3LG LAMB1 THBD IQSEC1 PLCB3 EDRF1	1.04e-05	189	176	7	732e8dcffcb634ca2968f9170c9c4b31dd5d4206
ToppCell	droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMB1 SVEP1 THBD FBN1 EFEMP1 ZFHX4 SLIT3	1.04e-05	189	176	7	bc54ffd7bd1627a36747a80ce5139e4a69928400
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 RAMP1 GFRA1 SVEP1 FBN1 AGTR1 SLIT3	1.08e-05	190	176	7	2306aa9dbeaef3be8484a5b236605de23cd75d4c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 RAMP1 SPEG NR2F2 SVEP1 FBN1 SLIT3	1.08e-05	190	176	7	70c86dd454afb21d4a85db56c5f369d4b342bc97
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 RAMP1 GFRA1 SVEP1 FBN1 AGTR1 SLIT3	1.08e-05	190	176	7	1f83f7f24288a3b9ab33c2e113e845dba96adc8a
ToppCell	droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMB1 SVEP1 THBD FBN1 EFEMP1 ZFHX4 SLIT3	1.08e-05	190	176	7	f3ca94a31a35eed5fecf3c4b8c957e1bc4150158
ToppCell	COVID-19-Heart-EC_3\|Heart / Disease (COVID-19 only), tissue and cell type	TPO VWF ADAM15 IFI44 ZNF521 THBD MCTP1	1.08e-05	190	176	7	78e7c502b0450c0b37652b1896a2a752fd8a2111
ToppCell	droplet-Mammary_Gland-nan-21m-Mesenchymal\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMB1 SVEP1 THBD FBN1 EFEMP1 ZFHX4 SLIT3	1.08e-05	190	176	7	c2cd1eb674162ee40502c3380b7245c85079c7ce
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 RAMP1 GFRA1 SVEP1 FBN1 AGTR1 SLIT3	1.12e-05	191	176	7	a58c75e9580139fb370b498d95660f10f3a2a27b
ToppCell	control-Myeloid-Neutrophils_1\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	UBR2 FBXL13 LITAF COP1 THBD ADGRE5 PLAUR	1.12e-05	191	176	7	db1b3cd07d7d190155b2d14e82e1d124975fbd0b
ToppCell	Control-Stromal_mesenchymal\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RAMP1 SPEG GFRA1 NR2F2 SVEP1 SLIT3 NOTCH2	1.12e-05	191	176	7	14057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 RAMP1 GFRA1 SVEP1 FBN1 AGTR1 SLIT3	1.16e-05	192	176	7	9093a9e94a25682d109a7f6edc256a25a61103a0
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 GFRA1 NR2F2 SVEP1 FBN1 ZFHX4 SLIT3	1.16e-05	192	176	7	d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 RAMP1 GFRA1 SVEP1 FBN1 AGTR1 SLIT3	1.16e-05	192	176	7	9ed5d49621ec1aa01716dc369bba1450b5f015f5
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell\|Adult / Lineage, Cell type, age group and donor	ITGA11 ZNF521 GFRA1 SVEP1 FBN1 EFEMP1 SLIT3	1.16e-05	192	176	7	d21f0f577156f17c899b08871046a26b88aea011
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 RAMP1 GFRA1 SVEP1 FBN1 AGTR1 SLIT3	1.20e-05	193	176	7	f1199518c3626fd29bfce65070dd21a660671213
ToppCell	5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TPO VWF MCHR1 ADAM15 THBD MCTP1 RASA4	1.20e-05	193	176	7	c0973a2c97deb7176c2f617c8760a55f7edc9839
ToppCell	facs-MAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMB1 NR2F2 SVEP1 THBD FBN1 EFEMP1 SLIT3	1.24e-05	194	176	7	f906b090f67df4cfe3498cdbb52cc0efa08e06cc
ToppCell	facs-MAT-Fat-18m-Mesenchymal\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMB1 NR2F2 SVEP1 THBD FBN1 EFEMP1 SLIT3	1.24e-05	194	176	7	944cdb0403d80a10a2eea2a3516a9343dbccc32c
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 RAMP1 SVEP1 FBN1 AGTR1 SLIT3 CHRD	1.24e-05	194	176	7	240d122dcb9dd1ab2867503ad85869853adcacae
ToppCell	COVID-19-Heart-Fib_2\|Heart / Disease (COVID-19 only), tissue and cell type	ITGA11 LAMB1 SVEP1 FBN1 EFEMP1 HMCN2 NOTCH2	1.24e-05	194	176	7	d91c9f2ec47319051fc398320693fddbe8bbd4d6
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 RAMP1 SVEP1 FBN1 AGTR1 SLIT3 CHRD	1.24e-05	194	176	7	ae7df037592f1c20c9d32be15fe6fc3c562ebeb1
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RAMP1 LAMB1 GFRA1 NR2F2 SVEP1 FBN1 SLIT3	1.24e-05	194	176	7	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 GFRA1 NR2F2 SVEP1 FBN1 ZFHX4 SLIT3	1.24e-05	194	176	7	e03ba6caed59fa64d4d9b042593469d4a6a3dc10
ToppCell	moderate-Epithelial-FOXN4+\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	TMEM67 ADAM15 RTTN G2E3 IFT122 ANKRD36 KNL1	1.24e-05	194	176	7	dff3fb10372053951d41e0ccd41aac3ece6009bd
ToppCell	facs-MAT-Fat-18m-Mesenchymal-mesenchymal_progenitor\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMB1 NR2F2 SVEP1 THBD FBN1 EFEMP1 SLIT3	1.24e-05	194	176	7	85081d255fcc1e9854c0073321dd9f0feaa48866
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 NR2F2 SVEP1 FBN1 AGTR1 SLIT3 ADGRE5	1.28e-05	195	176	7	d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 RAMP1 NR2F2 SVEP1 FBN1 ZFHX4 SLIT3	1.28e-05	195	176	7	49c99553629cdd83ee56a2e508d5bc8d34b8507b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 RAMP1 NR2F2 SVEP1 FBN1 ZFHX4 SLIT3	1.28e-05	195	176	7	dd281a249854800f737dc22e0f375f66dfb5cf5f
ToppCell	COVID-19-kidney-Fibroblast-2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ITGA11 GFRA1 NR2F2 SVEP1 FBN1 ZFHX4 SLIT3	1.28e-05	195	176	7	3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2
ToppCell	facs-Thymus-Thymus_Epithelium\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMB1 NR2F2 THBD FBN1 EFEMP1 ZFHX4 LRP2	1.32e-05	196	176	7	6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363
ToppCell	facs-Thymus-Thymus_Epithelium-18m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMB1 NR2F2 THBD FBN1 EFEMP1 ZFHX4 LRP2	1.32e-05	196	176	7	c8c89e469402e11aa2a9561e859b6fd1fb66c39b
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 RAMP1 NR2F2 SVEP1 FBN1 SLIT3 ADGRE5	1.32e-05	196	176	7	fa445f4240c521cf04eb2e2f79a5c55fda31209a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 RAMP1 NR2F2 SVEP1 FBN1 SLIT3 ADGRE5	1.32e-05	196	176	7	802f61e78a9a1030a86c4a980c398a73cd4d1574
ToppCell	5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TPO VWF ZNF521 NR2F2 THBD MCTP1 RASA4	1.37e-05	197	176	7	87eda06344498dc66cac292cf89746dc90b5cf67
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 GFRA1 SVEP1 FBN1 ZFHX4 AGTR1 SLIT3	1.37e-05	197	176	7	09946ee8dfb15a2a32da06e5b331f3277ee934f4
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	GPR4 VWF ZNF521 LAMB1 NR2F2 THBD ADAMTS18	1.37e-05	197	176	7	4e58bbf3ecb30b4c8199adcc04d2eb134d90de56
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 RAMP1 SVEP1 FBN1 AGTR1 SLIT3 ADGRE5	1.37e-05	197	176	7	6d027119a5f7ca2aac1b10837e43f9a2bb54db85
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMB1 GFRA1 SVEP1 FBN1 EFEMP1 AGTR1 SLIT3	1.37e-05	197	176	7	ab5d3ebc73bd7cfc64381d14b92878b370205186
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	LAMB1 GFRA1 SVEP1 FBN1 EFEMP1 AGTR1 SLIT3	1.37e-05	197	176	7	3bb92dd8a94e2be3b7fe51c9a21b241215477ac7
ToppCell	distal-3-Endothelial-Lymphatic\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ZNF521 NR2F2 THBD EFEMP1 ZFHX4 PIK3C2G SCNN1B	1.37e-05	197	176	7	9ea0e2ed9c3f97591a06e70570640996580417d5
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 RAMP1 SVEP1 FBN1 AGTR1 SLIT3 ADGRE5	1.37e-05	197	176	7	b349f8e96d61a4c296af64711e11fc44459a9413
ToppCell	mLN-(2)_B_cell-(20)_B_cell_IgA_Plasma\|mLN / shred on region, Cell_type, and subtype	TBX15 FNDC3B CECR2 TTC36 CLPTM1L FBN1 SCNN1B	1.37e-05	197	176	7	a39b384ee9824a08c3b544a9c3c7f0f95f08d6a7
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	LAMB1 GFRA1 SVEP1 FBN1 EFEMP1 AGTR1 SLIT3	1.37e-05	197	176	7	17344464fdcc5ba0c03959696b97c195f11e644c
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 RAMP1 GFRA1 SVEP1 FBN1 AGTR1 SLIT3	1.37e-05	197	176	7	4cf4e9553397cd8dee883dbec24f41bec41aff99
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	LAMB1 GFRA1 SVEP1 FBN1 EFEMP1 AGTR1 SLIT3	1.37e-05	197	176	7	5b8d0d7116b20d8e27541e88ec80c9f1f477e384
ToppCell	mLN-B_cell-B_cell_IgA_Plasma\|mLN / Region, Cell class and subclass	TBX15 FNDC3B CECR2 TTC36 CLPTM1L FBN1 SCNN1B	1.37e-05	197	176	7	20822fce311326765b71337ce501ba44ea14f58f
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 RAMP1 SVEP1 FBN1 AGTR1 SLIT3 ADGRE5	1.37e-05	197	176	7	c2e390653d5dee7e731c1840cfdab41987dede9b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 RAMP1 SVEP1 FBN1 ZFHX4 AGTR1 SLIT3	1.41e-05	198	176	7	79576525a10ed3e3a9d1608077cd16ecda23376f
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RAMP1 LAMB1 GFRA1 SVEP1 EFEMP1 HMCN2 ZFHX4	1.41e-05	198	176	7	12cd9f0bbad8dce5199ebfed1c4a8080710ca055
ToppCell	5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GPR4 VWF ZNF521 NR2F2 THBD MCTP1 RASA4	1.46e-05	199	176	7	07bda4ac8ffdce1a865ebc99e46c2a27925ff7a8
Drug	Rgd Peptide	RALGDS ITGA11 VWF ADAM15 SPEG LAMB1 THBD FBN1 AGTR1 ADGRE5 PLAUR FBN3	3.52e-07	239	175	12	CID000104802
Drug	Monensin sodium salt [22373-78-0]; Up 200; 5.8uM; MCF7; HT_HG-U133A	ADAM15 LDLR ZFPL1 SLC17A5 ADGRE5 PLCB3 BTRC SEC23A ZNF292	6.32e-06	168	175	9	3443_UP
Drug	Nsc34399	TECTA CHRM2 CHRM5	8.78e-06	6	175	3	CID000003622
Drug	dictamnine	KRT81 KRT83 AFM	8.78e-06	6	175	3	CID000068085
Drug	phenylacetaldehyde	RNLS SPINK1 COP1 PTBP1 ADHFE1 LOXL4 ALDH3A2	1.23e-05	100	175	7	CID000000998
Drug	3-sulfoglucuronic acid	THBD AGTR1 CHRD	1.53e-05	7	175	3	CID000130628
Drug	Famprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A	TGFB2 THBD TMEM209 MFN2 TMPO TNKS2 RECK EDRF1 SEC23A	1.85e-05	192	175	9	3753_DN
Drug	Methylhydantoin-5-(L) [40856-73-3]; Down 200; 35uM; MCF7; HT_HG-U133A	EPHB2 ABCA2 CDC42BPA IQSEC2 MUC5B ZFHX4 PLAUR UTY ZNF292	1.93e-05	193	175	9	3378_DN
Drug	Clofilium tosylate [92953-10-1]; Down 200; 7.8uM; PC3; HT_HG-U133A	EPHB2 ZNF821 ABCA2 SPEG IQSEC2 IDH3G NR2F2 SVEP1 BTRC	2.01e-05	194	175	9	4492_DN
Drug	5-methoxytryptophol	RNLS TECTA MALT1 LOXL4	2.21e-05	22	175	4	CID000012835
Drug	Meprylcaine hydrochloride [956-03-6]; Down 200; 14.8uM; MCF7; HT_HG-U133A	ABCA2 ADAM15 INTS1 LAMB1 ZFPL1 GSTCD TMEM209 TMPO NOTCH2	2.26e-05	197	175	9	3544_DN
Drug	Diprophylline [479-18-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A	ZNF821 CDC42BPA SLC17A5 RPAP1 HPS4 GSTCD LRP2 ZFYVE26 ALDH3A2	2.26e-05	197	175	9	5482_DN
Drug	Bezafibrate [41859-67-0]; Down 200; 11uM; MCF7; HT_HG-U133A	ASPHD1 ADAM15 LDLR ZFPL1 TGFB2 RPAP1 HPS4 TMPO SEC23A	2.36e-05	198	175	9	4999_DN
Drug	Sulfamerazine [127-79-7]; Down 200; 15.2uM; MCF7; HT_HG-U133A	EPHB2 UBR2 INTS7 ABCC5 TGFB2 THBD PLAUR BTRC ZNF292	2.45e-05	199	175	9	6036_DN
Drug	Ciprofibrate [52214-84-3]; Down 200; 13.8uM; PC3; HT_HG-U133A	EPHB2 ABCA2 CDC42BPA ERAP1 IFI44 SVEP1 TGFB2 LRP2 PLCB3	2.45e-05	199	175	9	5740_DN
Drug	Graveoline [485-61-0]; Down 200; 14.4uM; MCF7; HT_HG-U133A	INTS7 ADAM15 LAMB1 TRIM3 TGFB2 MALT1 ZFHX4 GSTCD BTRC	2.55e-05	200	175	9	6034_DN
Drug	Lilly 51641	RNLS ADHFE1 LOXL4	3.62e-05	9	175	3	CID000021485
Drug	dodecanal	TPO ADHFE1 ALDH3A2	3.62e-05	9	175	3	CID000008194
Drug	hematin	TPO KRT81 KRT83 TG GSTCD ALB	4.09e-05	82	175	6	CID000027337
Drug	melicopicine	KRT81 KRT83	5.87e-05	2	175	2	CID000101253
Drug	dimethyl-W84	CHRM2 CHRM5	5.87e-05	2	175	2	ctd:C113497
Drug	tebuquine	KRT81 KRT83	5.87e-05	2	175	2	CID000071991
Drug	3,5-di-O-galloylquinic acid	KRT81 KRT83	5.87e-05	2	175	2	CID000460896
Drug	Furazolidone-d4	RNLS HPS4 LOXL4 ALDH3A2	7.91e-05	30	175	4	CID000003435
Drug	Forskolin, from Coleus forskohlii; Up 200; 0.5uM; PC3; HT_HG-U133A	EPHB2 ERAP1 TRIM3 TGFB2 THBD FBN1 PACS2 PLCB3	8.86e-05	183	175	8	7059_UP
Drug	Ganciclovir [82410-32-0]; Down 200; 15.6uM; MCF7; HT_HG-U133A	ERAP1 SPEG TRIM3 TGFB2 RPAP1 ZFHX4 MIOS TMPO	1.03e-04	187	175	8	3368_DN
Drug	3-isoreserpine	ABCA2 RNLS ABCC5 CHRM2 LDLR SLC17A5 PIK3C2G LOXL4	1.15e-04	190	175	8	CID000005052
Drug	Homochlorcyclizine dihydrochloride [1982-36-1]; Up 200; 10.4uM; MCF7; HT_HG-U133A	RALGDS IQSEC2 LDLR SVEP1 FBXL5 THBD HPS4 ALDH3A2	1.19e-04	191	175	8	7417_UP
Drug	Quinacrine dihydrochloride dihydrate [6151-30-0]; Up 200; 7.8uM; HL60; HG-U133A	UBR2 DIDO1 MALT1 ZC2HC1A RPAP1 TRIM8 RECK SEC23B	1.19e-04	191	175	8	1563_UP
Drug	trioxane	KRT81 KRT83 HPS4	1.21e-04	13	175	3	CID000008081
Drug	Thalidomide [50-35-1]; Down 200; 15.4uM; MCF7; HT_HG-U133A	ASPHD1 INTS7 IQSEC2 MKRN2 ZFPL1 HPS4 UTY BTRC	1.24e-04	192	175	8	5990_DN
Drug	Pipenzolate bromide [125-51-9]; Up 200; 9.2uM; MCF7; HT_HG-U133A	ABCA2 IQSEC2 LAMB1 TRIM3 TGFB2 TMEM209 PLAUR EDRF1	1.24e-04	192	175	8	3460_UP
Drug	scriptaid; Down 200; 10uM; PC3; HT_HG-U133A	AIP PTBP1 ADNP LDLR ZFPL1 TMPO PLAUR NOTCH2	1.24e-04	192	175	8	6919_DN
Drug	radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; MCF7; HT_HG-U133A	UBR2 CDC42BPA ASPHD1 IQSEC2 DIDO1 CHRM5 EFEMP1 EDRF1	1.28e-04	193	175	8	6938_UP
Drug	genistein; Down 200; 10uM; MCF7; HT_HG-U133A	ZMYND11 PTBP1 LDLR ZFPL1 SLC17A5 MFN2 TMPO SEC23A	1.28e-04	193	175	8	5232_DN
Drug	Glycocholic acid [475-31-0]; Down 200; 8.6uM; PC3; HT_HG-U133A	CDC42BPA SPEG ZFPL1 TGFB2 MFN2 ALDH18A1 SEC23A NOTCH2	1.28e-04	193	175	8	6716_DN
Drug	AG-013608 [351320-38-2]; Down 200; 10uM; PC3; HT_HG-U133A	ZNF821 ADAM15 LDLR TGFB2 MFN2 ALDH18A1 BTRC NOTCH2	1.28e-04	193	175	8	5909_DN
Drug	harmaline	GJD2 RNLS TMPO LOXL4	1.31e-04	34	175	4	CID000022381
Drug	ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A	GPR4 ADAM15 AIP PTBP1 LDLR ALDH18A1 TMPO NOTCH2	1.33e-04	194	175	8	6918_DN
Drug	17-DMAG; Up 200; 0.1uM; PC3; HT_HG-U133A	GPR4 RALGDS FPGS IQSEC2 DIDO1 MUC5B HPS4 EDRF1	1.33e-04	194	175	8	1213_UP
Drug	Solanine alpha [20562-02-1]; Down 200; 4.6uM; MCF7; HT_HG-U133A	CDC42BPA FPGS TMEM209 TMPO ADGRE5 TNKS2 EDRF1 NOTCH2	1.38e-04	195	175	8	2808_DN
Drug	Tetrandrine [518-34-3]; Down 200; 6.4uM; MCF7; HT_HG-U133A	ZNF821 ABCA2 ASPHD1 IQSEC2 LAMB1 TRIM3 MALT1 PLCB3	1.38e-04	195	175	8	6082_DN
Drug	Dicumarol [66-76-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A	EPHB2 RALGDS MUC5B TRIM3 ZFPL1 MIOS ADGRE5 PLCB3	1.38e-04	195	175	8	3941_DN
Drug	Amikacin hydrate [37517-28-5]; Down 200; 6.6uM; MCF7; HT_HG-U133A	RALGDS ZNF821 ABCA2 CDC42BPA TMEM209 LRP2 HMGXB3 NOTCH2	1.42e-04	196	175	8	3233_DN
Drug	Chlorprothixene hydrochloride [6469-93-8]; Down 200; 11.4uM; MCF7; HT_HG-U133A	EPHB2 RALGDS CDC42BPA ADAM15 FBXL5 RPAP1 TMPO TNKS2	1.42e-04	196	175	8	2627_DN
Drug	Hydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A	ABCA2 IQSEC2 NR2F2 MALT1 HPS4 TMEM209 BTRC ZNF292	1.48e-04	197	175	8	6011_DN
Drug	Clozapine [5786-21-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A	EPHB2 ZNF821 LAMB1 ZFPL1 FBXL5 HPS4 IQSEC1 HMGXB3	1.48e-04	197	175	8	2644_DN
Drug	Suprofen [40828-46-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A	RAMP1 KRT83 IQSEC2 TRIM3 THBD MFN2 ADGRE5 BTRC	1.48e-04	197	175	8	4123_DN
Drug	Colistin sulfate [1264-72-8]; Up 200; 3uM; MCF7; HT_HG-U133A	RALGDS TRIM3 GSTCD TMEM209 MFN2 BTRC SEC23A NOTCH2	1.48e-04	197	175	8	4796_UP
Drug	Sulfabenzamide [127-71-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A	LAMB1 TRIM3 FBXL5 TMEM209 ADGRE5 HMGXB3 PLCB3 BTRC	1.48e-04	197	175	8	2814_DN
Drug	Alclometasone dipropionate [667634-13-2]; Down 200; 7.6uM; PC3; HT_HG-U133A	ABCA2 IFI44 MCTP1 LRP2 IFT122 BTRC EDRF1 NOTCH2	1.48e-04	197	175	8	5752_DN
Drug	fludrocortisone acetate; Up 200; 1uM; MCF7; HG-U133A	IDH3G LDLR TG SLIT3 TMPO UTY EDRF1 SEC23B	1.48e-04	197	175	8	281_UP
Drug	aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A	RALGDS ASPHD1 LAMB1 NR2F2 TGFB2 MALT1 PLCB3 EDRF1	1.48e-04	197	175	8	5564_DN
Drug	Niacin [59-67-6]; Down 200; 32.4uM; MCF7; HT_HG-U133A	ABCA2 CDC42BPA TRIM3 SLC17A5 ADGRE5 HMGXB3 UTY NOTCH2	1.48e-04	197	175	8	5301_DN
Drug	Memantine Hydrochloride [41100-52-1]; Up 200; 18.6uM; HL60; HT_HG-U133A	ZNF821 IQSEC2 IDH3G TRIM3 AGTR1 IQSEC1 MIOS UTY	1.48e-04	197	175	8	2934_UP
Drug	sodium perchlorate hydrate	TPO TG IFT122	1.53e-04	14	175	3	CID000516899
Drug	Diazoxide [364-98-7]; Down 200; 17.4uM; MCF7; HT_HG-U133A	EPHB2 ABCA2 RAMP1 ASPHD1 FPGS NR2F2 RPAP1 PLAUR	1.53e-04	198	175	8	7168_DN
Drug	Fipexide hydrochloride [34161-23-4]; Down 200; 9.4uM; PC3; HT_HG-U133A	ABCA2 IFI44 SVEP1 TGFB2 FBN1 PLCB3 UTY EDRF1	1.53e-04	198	175	8	5737_DN
Drug	Progesterone [57-83-0]; Down 200; 12.8uM; MCF7; HT_HG-U133A	EPHB2 RALGDS INTS1 RPAP1 TMPO PLAUR PLCB3 ESPL1	1.53e-04	198	175	8	4992_DN
Drug	Tranexamic acid [1197-18-8]; Up 200; 25.4uM; MCF7; HT_HG-U133A	ERAP1 ZFPL1 TGFB2 EFEMP1 GSTCD ADGRE5 ALDH3A2 BTRC	1.53e-04	198	175	8	6238_UP
Drug	Dimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; MCF7; HT_HG-U133A	EPHB2 CDC42BPA ERAP1 IQSEC2 DIDO1 RPAP1 PLAUR UTY	1.53e-04	198	175	8	4791_DN
Drug	Ethacrynic acid [58-54-8]; Down 200; 13.2uM; PC3; HT_HG-U133A	EPHB2 GPR4 ABCA2 ADAM15 DIDO1 TMEM209 LRP2 UTY	1.53e-04	198	175	8	5742_DN
Drug	Dubinidine [22964-77-8]; Down 200; 14.6uM; MCF7; HT_HG-U133A	ZNF821 ASPHD1 ZFPL1 RPAP1 GSTCD TNKS2 EDRF1 ZNF292	1.53e-04	198	175	8	3554_DN
Drug	Cyclopenthiazide [742-20-1]; Up 200; 10.6uM; MCF7; HT_HG-U133A	ZNF821 TRIM3 MALT1 THBD MCTP1 ZFHX4 BTRC EDRF1	1.53e-04	198	175	8	7325_UP
Drug	Rauwolscine hydrochloride [6211-32-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A	RALGDS TRIM3 RPAP1 ADGRE5 PLAUR PLCB3 TNKS2 EDRF1	1.58e-04	199	175	8	2778_DN
Drug	Artemisinin [63968-64-9]; Down 200; 14.2uM; PC3; HT_HG-U133A	GPR4 MUC5B IDH3G LDLR TGFB2 FBN1 MFN2 UTY	1.58e-04	199	175	8	7247_DN
Drug	Isoniazid [54-85-3]; Down 200; 29.2uM; HL60; HG-U133A	ABCA2 CDC42BPA ADAM15 ABCC5 IDH3G LDLR ALDH3A2 RECK	1.58e-04	199	175	8	1399_DN
Drug	semustine; Down 200; 100uM; MCF7; HT_HG-U133A	LAMB1 NR2F2 EFEMP1 GSTCD LRP2 TMPO PLAUR BTRC	1.58e-04	199	175	8	7487_DN
Drug	Ozagrel hydrochloride [78712-43-3]; Down 200; 15.2uM; PC3; HT_HG-U133A	FPGS IDH3G NR2F2 TRIM3 TGFB2 TMEM209 HMGXB3 PLCB3	1.58e-04	199	175	8	7281_DN
Drug	Ornidazole [16773-42-5]; Up 200; 18.2uM; MCF7; HT_HG-U133A	ABCA2 KRT83 TRIM3 MCTP1 ZFHX4 PIK3C2G TMEM209 SCNN1B	1.64e-04	200	175	8	2272_UP
Drug	sulfonamide-3	KRT81 KRT83	1.75e-04	3	175	2	CID009847197
Disease	MONILETHRIX	KRT81 KRT83 KRT86	1.75e-07	3	166	3	158000
Disease	Beaded hair	KRT81 KRT83 KRT86	1.75e-07	3	166	3	cv:C0546966
Disease	monilethrix (is_implicated_in)	KRT81 KRT83 KRT86	1.75e-07	3	166	3	DOID:0050472 (is_implicated_in)
Disease	Monilethrix	KRT81 KRT83 KRT86	6.97e-07	4	166	3	C0546966
Disease	end stage renal disease (is_marker_for)	VWF RNLS THBD PLAUR ALB	6.03e-06	46	166	5	DOID:783 (is_marker_for)
Disease	cerebral palsy (implicated_via_orthology)	AGAP7P AGAP4 AGAP6	2.04e-05	10	166	3	DOID:1969 (implicated_via_orthology)
Disease	congenital dyserythropoietic anemia type II (implicated_via_orthology)	SEC23B SEC23A	3.15e-05	2	166	2	DOID:0111401 (implicated_via_orthology)
Disease	craniolenticulosutural dysplasia (implicated_via_orthology)	SEC23B SEC23A	3.15e-05	2	166	2	DOID:0070307 (implicated_via_orthology)
Disease	hair disease (is_implicated_in)	KRT81 KRT86	3.15e-05	2	166	2	DOID:421 (is_implicated_in)
Disease	connective tissue disease (implicated_via_orthology)	FBN1 FBN3	9.40e-05	3	166	2	DOID:65 (implicated_via_orthology)
Disease	Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 measurement	ADAM15 SVEP1	1.87e-04	4	166	2	EFO_0803113
Disease	Roberts syndrome (implicated_via_orthology)	SEC23B SEC23A	1.87e-04	4	166	2	DOID:5325 (implicated_via_orthology)
Disease	Intellectual Disability	RALGDS ZMYND11 RTTN ZBTB24 TRIM8 IQSEC1 LRP2 PACS2 ALDH3A2 ZNF292	2.34e-04	447	166	10	C3714756
Disease	myocardial infarction (biomarker_via_orthology)	VWF TGFB2 AGTR1 MFN2 PLAUR PLCB3	3.01e-04	160	166	6	DOID:5844 (biomarker_via_orthology)
Disease	3-methylcytidine measurement	FBXL5 LOXL4	3.11e-04	5	166	2	EFO_0800633
Disease	Thyroid Dyshormonogenesis 1	TPO TG	4.65e-04	6	166	2	C1848805
Disease	familial combined hyperlipidemia (is_marker_for)	VWF THBD	4.65e-04	6	166	2	DOID:13809 (is_marker_for)
Disease	level of Sphingomyelin (d42:2) in blood serum	LDLR PELP1 PCSK9	5.74e-04	29	166	3	OBA_2045183
Disease	LDL cholesterol change measurement	LDLR PCSK9	6.49e-04	7	166	2	EFO_0007804
Disease	Aortic Aneurysm, Thoracic	TGFB2 FBN1	6.49e-04	7	166	2	C0162872
Disease	Goiter	TPO TG	6.49e-04	7	166	2	C0018021
Disease	Aortic Aneurysm, Thoracoabdominal	TGFB2 FBN1	6.49e-04	7	166	2	C0340630
Disease	pulse pressure measurement, anxiety	GJA9 GJA10	6.49e-04	7	166	2	EFO_0005230, EFO_0005763
Disease	Autistic Disorder	ZMYND11 COP1 LAMB1 XPC ADNP PLAUR ZNF292	7.19e-04	261	166	7	C0004352
Disease	refractive error, age at onset, Myopia	FNDC3B GJD2 RNLS FBN1 EFEMP1 RORB	8.09e-04	193	166	6	EFO_0004847, HP_0000545, MONDO_0004892
Disease	Abnormality of the skeletal system	INTS1 ZNF292	8.61e-04	8	166	2	C4021790
Disease	mesangial proliferative glomerulonephritis (biomarker_via_orthology)	VWF FBN1	8.61e-04	8	166	2	DOID:4783 (biomarker_via_orthology)
Disease	Familial hypercholesterolemia	LDLR PCSK9	8.61e-04	8	166	2	cv:C0020445
Disease	diastolic blood pressure, self reported educational attainment	PIK3C2G SLIT3	8.61e-04	8	166	2	EFO_0004784, EFO_0006336
Disease	Pituitary Neoplasms	AIP AGTR1	8.61e-04	8	166	2	C0032019
Disease	refractive error, self reported educational attainment	GJD2 DIS3L FBN1	9.20e-04	34	166	3	EFO_0004784, MONDO_0004892
Disease	monocyte percentage of leukocytes	UBR2 FLT3LG CDC42BPA RNLS LITAF CECR2 IQSEC2 MKRN2 ABCC5 ZC2HC1A HMGXB3 PLAUR	9.26e-04	731	166	12	EFO_0007989
Disease	multiple myeloma (is_marker_for)	FLT3LG ALB NOTCH2	1.09e-03	36	166	3	DOID:9538 (is_marker_for)
Disease	Kunitz-type protease inhibitor 1 measurement	GJD2 GJA9	1.10e-03	9	166	2	EFO_0008199
Disease	aortic aneurysm	TGFB2 FBN1	1.37e-03	10	166	2	EFO_0001666
Disease	familial hypercholesterolemia (is_implicated_in)	LDLR PCSK9	1.37e-03	10	166	2	DOID:13810 (is_implicated_in)
Disease	glomerulosclerosis (biomarker_via_orthology)	RNLS AGTR1	1.37e-03	10	166	2	DOID:0050851 (biomarker_via_orthology)
Disease	Liver Cirrhosis, Experimental	VWF RAMP1 ERAP1 TTC36 ABCC5 GFRA1 THBD ADHFE1 FBN1 AFM ALB RECK	1.50e-03	774	166	12	C0023893
Disease	photoreceptor cell layer thickness measurement	UBR2 CDC42BPA ATE1 RORB IFT122	1.54e-03	148	166	5	EFO_0803370
Disease	Kidney Diseases	AGTR1 LRP2 IFT122 ALB	1.56e-03	88	166	4	C0022658
Disease	Diaphragmatic Hernia	NR2F2 SLIT3 LRP2	1.59e-03	41	166	3	C0019284
Disease	amino acid measurement	EPHB2 ITGA11 VWF LITAF LAMB1 CHRM2 PELP1 SLIT3 SCNN1B LRP2 TNKS2	1.65e-03	678	166	11	EFO_0005134
Disease	Autoimmune Diseases	TPO TG TGFB2	1.71e-03	42	166	3	C0004364
Disease	congenital diaphragmatic hernia (implicated_via_orthology)	NR2F2 SLIT3	2.00e-03	12	166	2	DOID:3827 (implicated_via_orthology)
Disease	autoimmune thyroiditis (is_implicated_in)	TG LRP2	2.00e-03	12	166	2	DOID:7188 (is_implicated_in)
Disease	familial hyperlipidemia (implicated_via_orthology)	LDLR ALB	2.00e-03	12	166	2	DOID:1168 (implicated_via_orthology)
Disease	Endometrioma	LAMB1 NR2F2 TGFB2 FBN1 RORB	2.22e-03	161	166	5	C0269102
Disease	Endometriosis	LAMB1 NR2F2 TGFB2 FBN1 RORB	2.22e-03	161	166	5	C0014175
Disease	Congenital Hypothyroidism	TPO TG	2.36e-03	13	166	2	C0010308
Disease	atherosclerosis	SLC17A4 LDLR	2.36e-03	13	166	2	EFO_0003914
Disease	pancreatic cancer (is_marker_for)	ADAM15 ABCC5 ADGRE5 ALB	2.58e-03	101	166	4	DOID:1793 (is_marker_for)
Disease	obesity (is_marker_for)	VWF THBD MFN2 PLAUR	2.58e-03	101	166	4	DOID:9970 (is_marker_for)
Disease	Malignant neoplasm of prostate	EPHB2 SPINK1 LITAF USP28 ARHGEF5 CLPTM1L GSTCD LRP2 PLAUR ZNF292	2.66e-03	616	166	10	C0376358
Disease	congenital hypothyroidism (implicated_via_orthology)	TPO TG	2.74e-03	14	166	2	DOID:0050328 (implicated_via_orthology)
Disease	serum IgG glycosylation measurement	TPO ITGA11 IFI44 LAMB1 GFRA1 EFEMP1 MCTP1 SLIT3 RECK	2.94e-03	523	166	9	EFO_0005193
Disease	Hernia	TGFB2 EFEMP1 HMCN2	2.99e-03	51	166	3	HP_0100790
Disease	Proteinuria	VWF LRP2	3.15e-03	15	166	2	HP_0000093
Disease	response to statin, LDL cholesterol change measurement	LDLR PCSK9	3.15e-03	15	166	2	EFO_0007804, GO_0036273
Disease	level of Sterol ester (27:1/18:1) in blood serum	LDLR PCSK9	3.58e-03	16	166	2	OBA_2045195
Disease	primary autosomal recessive microcephaly (is_implicated_in)	NCAPD2 KNL1	3.58e-03	16	166	2	DOID:0070296 (is_implicated_in)
Disease	Neoplasm Invasiveness	TBX15 XPC PLAUR RECK NOTCH2	3.93e-03	184	166	5	C0027626
Disease	waist-hip ratio	EPHB2 TBX15 FNDC3B ITGA11 ZMYND11 LITAF SLC17A4 LAMB1 CHRM2 RNF157 MARCHF5 TRIM8 PLCB3 IFT122 KNL1	4.01e-03	1226	166	15	EFO_0004343
Disease	Eye Abnormalities	TGFB2 IFT122	4.05e-03	17	166	2	C0015393
Disease	ischemia (implicated_via_orthology)	ADNP SCNN1B	4.05e-03	17	166	2	DOID:326 (implicated_via_orthology)
Disease	Hypermetropia, Myopia	TMEM67 GJD2 RNLS EFEMP1 RORB	4.41e-03	189	166	5	HP_0000540, HP_0000545
Disease	Hypertensive disease	VWF ERAP1 AGTR1 SCNN1B ALB	4.51e-03	190	166	5	C0020538
Disease	androstenedione measurement, estrone measurement	OR4D1 OR4D2	4.54e-03	18	166	2	EFO_0007970, EFO_0007972
Disease	sinusitis (is_marker_for)	MUC5B PLAUR	4.54e-03	18	166	2	DOID:0050127 (is_marker_for)
Disease	essential hypertension (is_implicated_in)	RNLS AGTR1	4.54e-03	18	166	2	DOID:10825 (is_implicated_in)
Disease	level of Sphingomyelin (d34:1) in blood serum	LDLR PCSK9	4.54e-03	18	166	2	OBA_2045175
Disease	Hypercholesterolemia, Familial	LDLR PCSK9	4.54e-03	18	166	2	C0020445
Disease	low density lipoprotein cholesterol measurement, phospholipid measurement	LDLR NPC1L1 PLAUR PCSK9	4.79e-03	120	166	4	EFO_0004611, EFO_0004639
Disease	diastolic blood pressure, systolic blood pressure	TBX15 FNDC3B SPINK1 ADAM15 SPEG FBN1 EFEMP1 PELP1 LOXL4 BTRC	4.79e-03	670	166	10	EFO_0006335, EFO_0006336
Disease	Abnormality of refraction	EPHB2 FNDC3B GJD2 RNLS PTBP1 FBN1 EFEMP1 RORB FBN3 SEC23B	4.94e-03	673	166	10	HP_0000539
Disease	bipolar disorder (is_marker_for)	VWF CHRM2	5.05e-03	19	166	2	DOID:3312 (is_marker_for)
Disease	smoking behavior, BMI-adjusted waist circumference	TBX15 FNDC3B TGFB2 EFEMP1	5.07e-03	122	166	4	EFO_0004318, EFO_0007789
Disease	BMI-adjusted waist circumference, physical activity measurement	TBX15 FNDC3B TGFB2 EFEMP1	5.22e-03	123	166	4	EFO_0007789, EFO_0008002
Disease	citrulline measurement	HMCN2 ALDH18A1	5.59e-03	20	166	2	EFO_0009777

Protein segments in the cluster

Peptide	Gene	Start	Entry
FENRILLNCPYCTFN	ADNP	101	Q9H2P0
SQECINVLLQYGCPD	AGAP4	646	Q96P64
DNNRCPKCNYVVDNI	COP1	166	Q8NHY2
ECCVYIPNNSRNISL	ERVPABLB-1	401	P60509
PCAEDYLSVVLNQLC	ALB	471	P02768
LALAQSQYAQAPCCP	ANTXRL	476	A6NF34
NTLQPGCNQACYDRA	GJD2	56	Q9UKL4
CQLKGPTCQYRAAQS	ADAM15	726	Q13444
IYKDLLRNCCNTENP	AFM	376	P43652
ITICIAYFNNCLNPL	AGTR1	286	P30556
LLECYNSPQVQCLRA	ARHGEF5	1506	Q12774
CNNICYDDAFPISLI	GJA10	61	Q969M2
LRQTYNSCARLCLNQ	BTRC	76	Q9Y297
QNLPRCGIECKSYQE	AAR2	176	Q9Y312
DVDECQQNPRLCKSY	ADGRE5	116	P48960
RQELSYQNLLNVSCC	ANKRD40CL	31	Q53H64
CIAPDYILCEASLQN	ALDH3A2	241	P51648
INSTINPACYALCNA	CHRM2	431	P08172
QCLNRSLYRPDAVAQ	ANKRD36	341	A6QL64
QPETIACACIYLAAR	CCNL1	241	Q9UK58
ACACIYLAARALQIP	CCNL1	246	Q9UK58
QNADCINIPGSYRCK	FBN3	1776	Q75N90
ACLLQGCYQRRDITP	CECR2	61	Q9BXF3
SSRIYQLCNINPCNE	ADAMTS18	631	Q8TE60
LDQQITPLLLNYCQC	AIP	226	O00170
SQECINVLLQYGCPD	AGAP6	646	Q5VW22
CAIASCRQQGSPRYL	CRISP1	156	P54107
NEQQLCPYAAAGECR	MKRN2	166	Q9H000
VPCQSLEAYAELCRA	MUC5B	5326	Q9HC84
GRPQTAYLQCKCVNE	RASA4	646	O43374
ACQEANYGALLRELC	RAMP1	26	O60894
GRPQTAYLQCKCVNE	RASA4B	646	C9J798
DVREPCQLGCRNLTY	RECK	341	O95980
QYECVPRQLACDQVQ	RECK	706	O95980
LSYTCRANRNCPIDQ	NR2F2	111	P24468
NIQALCECALQTPYD	INTS7	291	Q9NVH2
RFYCNNENCSLPLVL	PIK3C2G	681	O75747
LQDVDHYCPNCRALL	LITAF	141	Q99732
RCIDLVNGYQCNCQP	NOTCH2	621	Q04721
NFYCDVPQVLRLACT	OR4D2	176	P58180
LCAYQAEPNTCATAQ	PTPRN	716	Q16849
YLERQLAPENCCFAA	KLHL34	121	Q8N239
TNCPTGLQRRYACAN	LOXL4	646	Q96JB6
LCYRCSTNNPLLNNL	IFT122	1056	Q9HBG6
FCRAELQNPYCKNVQ	MCTP1	436	Q6DN14
NPAEAVQVLRYCCLL	MOV10L1	1036	Q9BXT6
CNQQLDLALCRAYEA	TMPO	561	P42166
LRQLCQYQRCVPQDT	INTS1	1436	Q8N201
PNPYRSENCLCVQNI	MALT1	431	Q9UDY8
SYRALRCPACNENGL	GRXCR2	226	A6NFK2
YCDVDSVSARQPLCQ	EDRF1	1006	Q3B7T1
LQLPKACAYQCHNLQ	HMCN2	4761	Q8NDA2
QLLLYQAGRCQPSNC	ASPHD1	251	Q5U4P2
SCADTLRYQANNCPI	MGRN1	301	O60291
RLIEAFSQRYCICNP	IQSEC1	626	Q6DN90
LIEAFSQRYCVCNPA	IQSEC2	856	Q5JU85
SQRYCVCNPALVRQF	IQSEC2	861	Q5JU85
YQNRECCQSNLEPLF	KRT86	141	O43790
EVCPLNGCDYIVSNR	FANCM	1846	Q8IYD8
VRNASTAVYACCNPI	HPS4	651	Q9NQG7
VALCADLCYPELTNQ	HMGXB3	1106	Q12766
QLCAYRRLQALQPCS	MBD3L5	86	A6NJ08
LLLLACVHNYQPCVQ	ERAP1	731	Q9NZ08
ACTRCGDNVQYAPRQ	EPHB2	371	P29323
TRQNFSRCLELQCQP	FLT3LG	146	P49771
YAIARCCLLPQANCS	PCSK9	521	Q8NBP7
CLANKYRPITGACNN	TPO	146	P07202
QLCAYRRLQALQPCS	MBD3L2B	86	A0A1B0GVZ6
ARVACPQCNAEYLIV	MARCHF5	61	Q9NX47
RSCYQDPVTLQLACV	LAMB1	931	P07942
DNYSCLPNVISCTDN	KNL1	1326	Q8NG31
NSNICIPRVYLCDGD	LRP2	2831	P98164
CQRVLRKPAQDCSAY	ITGA11	806	Q9UKX5
LFSCNRNVLAAACPY	KBTBD7	81	Q8WVZ9
CQVCQSAYSQLAGLR	PRDM12	301	Q9H4Q4
IVSRIQRYCNCNSQP	PACS2	531	Q86VP3
DALSPQLQQLACECY	PELP1	226	Q8IZL8
QLQQLACECYSRLPS	PELP1	231	Q8IZL8
GNTYPNECVLCFENR	SPINK1	51	P00995
SLNCVADPILYCLVN	GPR4	276	P46093
QLCAYRRLQALQPCS	MBD3L3	86	A6NE82
LVPRQCFSLNYDLNC	MFN2	516	O95140
CEYPAACNALETLLI	ALDH18A1	606	P54886
NPDNTSLYDCCINSL	NPC1L1	476	Q9UHC9
HYVCLRNEANQPLCL	PLCB3	821	Q01970
QCLRYIANLISCFPS	GLYATL3	176	Q5SZD4
EERYNSVLNSCCLRP	ABCC5	651	O15440
VQDYRPGACFNIICN	GAL3ST1	126	Q99999
CNNCLAIPITNTYKE	G2E3	666	Q7L622
ACLVQCSREAAPQDY	ESPL1	126	Q14674
LFLQCCREVAARYPQ	IDH3G	231	P51553
LDRCCNQGPTLTVIY	IFI44	41	Q8TCB0
PNCLNLQDSCKTNYI	GFRA1	241	P56159
CRNVCYDQAFPISLI	GJA9	61	P57773
AFYERRSCLPQLNCE	ENTR1	26	Q96C92
CYTALTNGRCSNQLP	FBN1	336	P35555
DINECAQNPLLCAFR	FBN1	2206	P35555
AQNPLLCAFRCVNTY	FBN1	2211	P35555
QPESIACACIYLAAR	CCNL2	236	Q96S94
DLLPAAQYCCRLQAF	FNDC3B	826	Q53EP0
LFANEFQQCCYLPRE	DIS3L	116	Q8TF46
NPLEQCCYNDAIVSL	IGFL2	46	Q6UWQ7
QVLLAYSRCLQACGQ	DDX12P	766	Q92771
LLERNGEDYICPNCT	DIDO1	306	Q9BTC0
ELLQVQQSLGYCPQC	ABCA2	2121	Q9BZC7
SQECINVLLQYGCPD	AGAP7P	646	Q5VUJ5
SERCPNLNYLSLRNC	FBXL13	501	Q8NEE6
SSALPLYNQQVGDCC	RALGDS	786	Q12967
ANSCLNPFVYIVLCE	MCHR1	371	Q99705
CLPSLENSKYCRFNQ	ATE1	441	O95260
LRDRAQQISCPLYLC	FPGS	266	Q05932
YVCPGTECQLLRLQA	HS6ST2	171	Q96MM7
IFSYLNPQELCRCSQ	FBXL5	216	Q9UKA1
AQILACYRKNCASPS	SEC24C	876	P53992
RYIVCSLAQQDCSPG	SLC17A4	266	Q9Y2C5
AAPVCCSARYNLAIL	SLC17A5	31	Q9NRA2
ILACLFGAEPCNYRN	SCNN1B	246	P51168
QNCCLPAVVERSDNF	GSTCD	86	Q8NEC7
CCTRNAYLSDLLPEN	HELB	781	Q8NG08
LFPCNRNVLAAACPY	KBTBD6	81	Q86V97
YQNRECCQSNLEPLF	KRT83	146	P78385
QLCAYRRLQALQPCS	MBD3L4	86	A6NDZ8
NFYCDVPQVLRLACT	OR4D1	176	Q15615
CCRENGVRNLSVPLY	OTOGL	2316	Q3ZCN5
QLCAYRRLQALQPCS	MBD3L2	86	Q8NHZ7
YLLRQLQRAACQCPT	ADHFE1	11	Q8IWW8
NNQYFDISALSCVPC	TMEM67	51	Q5HYA8
CNLPIKVVCRANAEY	MTX2	51	O75431
QNPLLGRACESCYAT	MTA3	371	Q9BTC8
ICQCNQGYELSSDRL	EFEMP1	276	Q12805
LQLLCVYTANFPNGC	RTTN	1971	Q86VV8
RLRDEQLNAPYSCQA	TARS3	31	A2RTX5
SCNQPQDAIKCYLNA	UTY	361	O14607
RANCEYQCQPLNQTS	THBD	371	P07204
CADTLRYQANNCPIC	RNF157	301	Q96PX1
LALDGQNIYNACCTL	PTBP2	236	Q9UKA9
ACPYCGARNLDQQEL	RNF166	151	Q96A37
CRESQLCNLNLSDYP	TBX15	386	Q96SF7
NEVNCPLQVALECLY	TEKT5	181	Q96M29
PCRNQATCVDELNSY	SVEP1	1391	Q4LDE5
ICLYDECNNSPLRRE	CDC42BPA	36	Q5VT25
CRAVLNPLCQVDYRA	SEC23A	66	Q15436
CKAVLNPLCQVDYRA	SEC23B	66	Q15437
VNSTVNPICYALCNR	CHRM5	486	P08912
CSGDANCIQPYLARR	CLPTM1L	36	Q96KA5
CCYRLLENPTINHQK	NCAPD2	201	Q15021
NYDPLCSLCTCQRRT	CHRD	721	Q9H2X0
VLLQTSPCDQYECQN	SLIT3	1116	O75094
QGSCAYLLARQCLQT	TECTA	341	O75443
RNVQDNCCLRPLYID	TGFB2	311	P61812
LQYQCDQCTVAFPTL	ZFHX4	2446	Q86UP3
LENLPQNGRQCYSCK	PLAUR	206	Q03405
PYECNQCGRAFSQLA	ZNF135	521	P52742
QVYLQCGTPCNLTCR	VWF	656	P04275
RLRQNADQCCPEYEC	VWF	2311	P04275
CSTLRLQLNNPYLCV	MIOS	576	Q9NXC5
QPDDDQYCLRICRVS	SPEG	1441	Q15772
NPQCTADLGAQYITC	RNLS	51	Q5VYX0
ECSPNEDRAALQCVY	ZNF521	271	Q96K83
NNASYSCPRQRNCLI	RORB	51	Q92753
VPAVEAATDYCQQLC	ZNF292	41	O60281
AAEYQDCNPQACPVR	SEMA5B	896	Q9P283
CSYLGQDIAENLQLC	USP28	1011	Q96RU2
AQACQDLPSIRNCYL	RPAP1	1046	Q9BWH6
LQILDLSGNCPRCYN	TLR7	251	Q9NYK1
LQTCRLLLSYGCDPN	TNKS2	446	Q9H2K2
YQLACRSQAPCANKD	TMEM209	291	Q96SK2
SCPECNLQFARLDNL	ZBTB24	491	O43167
QCPYCQRRFNENAAD	ZC2HC1A	121	Q96GY0
QLCKNCFYLSNARPD	ZMYND11	256	Q15326
QAICLLPERASAYNN	TTC36	76	A6NLP5
PAGILLVCNNCAAYR	ZNF821	231	O75541
LCLLANGFYRNNICS	XPC	211	Q01831
DSGLVRCPECNQAYN	TRIM8	46	Q9BZR9
LCSYLSLPNNLICLF	UBR2	1546	Q8IWV8
LDGQNIYNACCTLRI	PTBP1	241	P26599
VPSCRRNGDYQAVQC	TG	316	P01266
LARCQQYLCSIPDSL	ZFYVE26	556	Q68DK2
DSDYNPNCRLCNIPL	ZFPL1	46	O95159
FCERCLQNYIPAQSL	TRIM3	41	O75382
ALCRSLQAYASLCAQ	ZAN	1781	Q9Y493
YECLCPDGFQLVAQR	LDLR	336	P01130
YQNRECCQSNLEPLF	KRT81	141	Q14533
ILCDALRYPNCNIQR	NLRP14	976	Q86W24